Cognitive behavioral therapy for stress-related disorders by Lindsäter, Elin
From DEPARTMENT OF CLINICAL NEUROSCIENCE 
Karolinska Institutet, Stockholm, Sweden 






 All previously published papers were reproduced with permission from the publisher. 
Published by Karolinska Institutet. 
Printed by Eprint AB 2020 
© Elin Lindsäter, 2020 
ISBN 978-91-7831-667-0 
Cognitive Behavioral Therapy for Stress-Related Disorders 




Associate Professor Erik Hedman-Lagerlöf 
Karolinska Institutet 
Department of Clinical Neuroscience 




Professor Mats Lekander 
Karolinska Institutet 
Department of Clinical Neuroscience 
Division of Psychology & Osher Center for 
Integrative Medicine 
Stockholm University 
Stress Research Institute 
 
Associate Professor Brjánn Ljótsson 
Karolinska Institutet 
Department of Clinical Neuroscience 
Division of Psychology & Center for  
Psychiatry Research 
 
Professor Torbjörn Åkerstedt 
Karolinska Institutet 
Department of Clinical Neuroscience 
Division of Psychology 
Stockholm University 
Stress Research Instiute 
Opponent: 
Professor Ulrika von Thiele Schwarz 
Mälardalen University Sweden 
School of Health, Care, and Social Welfare 
Karolinska Institutet 
Department of Learning, Informatics, 
Managemeng and Ethics (LIME)  
 
Examination Board: 
Professor Anna Stigsdotter Neely 
Karlstad University 
Department of Social and Psychological Studies 




Docent Victoria Blom 
The Swedish School of Sport and Health Sciences 
Karolinska Institutet 
Department of Clinical Neuroscience 
Division of Insurance Medicine  
 
Professor Örjan Sundin 
Mid Sweden University 
Department of Psychology and Social Work 















                 To Julia, Majken, and Lovis 
  
ABSTRACT 
Background: Stress-related disorders in the form of adjustment disorder (AD) and 
exhaustion disorder (ED) are prevalent and associated with significant suffering, functional 
impairment and high societal costs. Cognitive behavioral therapy (CBT) may be effective in 
reducing stress, but studies using clinical samples diagnosed with stress-related disorders are 
few, and evidence is lacking to support treatment guidelines. Because accessibility to CBT is 
limited, it is important to investigate treatment delivery formats that enable high scalability. 
Health economic evaluations of treatments are needed to guide decision makers in how to use 
limited healthcare resources efficiently. Further, the study of potential mediators of treatment 
effect is important to inform treatment development for patients diagnosed with AD or ED. 
Aims: The overall aim of Study I was to evaluate the effect of CBT, a return-to-work 
intervention (RTW-I), and a combination of the two (COMBO) for patients on sick leave due 
to a common mental disorder (CMD; AD, ED, anxiety disorders, depression, and insomnia). 
Of particular interest to the present thesis was to evaluate the effect of a new CBT protocol 
used to treat patients with stress-related disorders in Study I. In Study II, the aim was to 
evaluate the efficacy of that same CBT protocol when delivered as a therapist-guided 
internet-based treatment (ICBT) for individuals with AD or ED. In Study III, we aimed to 
investigate cost-effectiveness of the ICBT. In Study IV, we aimed to investigate sleep 
impairment as a putative mediator of the effect of ICBT on symptoms of stress and 
exhaustion. 
Methods: In Study I, consecutively recruited primary care patients (N = 211) who were on 
sick leave due to a CMD were randomized to disorder specific CBT, a RTW-I, or to 
COMBO. Main outcomes were symptom severity and net days on sick leave. Of the total 
sample, a majority (72%) of patients met diagnostic criteria for AD or ED and were treated 
with the new CBT protocol for stress-related disorders. In Study II, nationally recruited 
participants (N = 100) diagnosed with AD or ED were randomized to ICBT for stress-related 
disorders or to a waitlist control condition (WLC). Level of perceived stress was the main 
outcome. Studies III and IV were based on data collected in Study II. In Study III, cost-
effectiveness and cost-utility of the ICBT were evaluated from a societal and a healthcare 
perspective, using remission rates and health-related quality of life to calculate incremental 
cost-effectiveness and cost-utility ratios respectively. In Study IV, weekly measurements of 
sleep impairment (the putative mediator) and outcomes (perceived stress and exhaustion) 
throughout the course of ICBT were analyzed using latent growth models within a structural 
equation framework.  
Results: Results of Studies I and II indicated that the CBT for stress-related disorders was 
effective in reducing symptoms compared with the RTW-I and the WLC respectively. 
Subgroup analyses of AD and ED in Study II indicated that the treatment was equally 
effective for both diagnostic groups. Treatment effect on sick leave (Study I) and work ability 
(Study II) was, however, small and non-significant compared with control conditions. Results 
from Study III suggested that, compared with the WLC, ICBT was a cost effective treatment, 
  
yielding large effects at no or minimal societal net costs in only 12 weeks. In Study IV, 
reduced sleep impairment was found to statistically mediate the effect of ICBT on symptoms 
of perceived stress and exhaustion.  
Conclusions: A relatively short CBT protocol designed to meet the presumed needs of 
patients diagnosed with AD or ED was indicated to be effective in reducing symptoms both 
when delivered as a face-to-face treatment and when delivered via the internet. If 
implemented in routine care, ICBT has the potential to increase access to efficacious 
treatment for many suffering individuals at no additional societal net costs. Reduced sleep 
impairment may be of importance to achieve successful treatment outcomes. The results 
motivate further investigation of the treatment using different control groups, longer follow-
up periods, and more fine-grained evaluations of treatment mechanisms. Further investigation 
into interventions that may have an effect on work-related outcomes is warranted. 
  
LIST OF SCIENTIFIC PAPERS 
I. Salomonsson, S., Santoft, F., Lindsäter, E., Ejeby, K., Ljótsson, B., Öst, L-G., 
Ingvar, M., Lekander, M., Hedman-Lagerlöf, E. (2017). Cognitive-
behavioural therapy and return-to-work intervention for patients on sick leave 
due to common mental disorders: a randomised controlled trial. Occupational 
and Environmental Medicine, 74(12), 905-912. Doi: 10.1136/oemed-2017-
104342 
 
II. Lindsäter, E., Axelsson, E., Salomonsson, S., Santoft, F., Ejeby, K., Ljótsson, 
B., Åkerstedt, T., Lekander, M., Hedman-Lagerlöf, E. (2018). Internet-based 
Cognitive Behavioral Therapy for Chronic Stress: A Randomized Controlled 
Trial. Psychotherapy and Psychosomatics, 87(5), 296-305. Doi: 
10.1159/000490742 
 
III. Lindsäter, E., Axelsson, E., Salomonsson, S., Santoft, F., Ljótsson, B., 
Åkerstedt, T., Lekander, M., Hedman-Lagerlöf, E. (2019). Cost-Effectiveness 
of Therapist-Guided Internet-Based Cognitive Behavioral Therapy for Stress-
Related Disorders: Secondary Analysis of a Randomized Controlled Trial. 
Journal of Medical Internet Research, 21(8), e14675. Doi: 10.2196/14675 
 
IV. Lindsäter, E., Axelsson, E., Salomonsson, S., Santoft, F., Ljótsson, B., 
Åkerstedt, T., Lekander, M., Hedman-Lagerlöf, E. (Manuscript). The 
Mediating Role of Sleep in Internet-Based Cognitive Behavioral Therapy for 




1 Introduction ..................................................................................................................... 9 
2 Background .................................................................................................................... 10 
2.1 Stress and stress-related disorders ....................................................................... 10 
2.1.1 Definition of stress .................................................................................. 10 
2.1.2 Stress-related disorders ........................................................................... 12 
2.1.3 Clinical correlates .................................................................................... 19 
2.1.4 Socioeconomic implications ................................................................... 20 
2.1.5 Potential risk- and protective factors ...................................................... 21 
2.1.6 Maintaining mechanisms – a cognitive behavioral approach ................ 23 
2.2 Cognitive Behavioral Therapy ............................................................................ 26 
2.2.1 Common treatment techniques and protocols ........................................ 26 
2.2.2 Randomized controlled trials of face-to-face CBT ................................ 31 
2.2.3 Therapist-guided internet-based CBT .................................................... 33 
2.2.4 Health economic effects .......................................................................... 34 
2.2.5 Mediators of change ................................................................................ 35 
2.3 Summary and current directions ......................................................................... 37 
3 Aims of the thesis .......................................................................................................... 38 
3.1 Study I .................................................................................................................. 38 
3.2 Study II ................................................................................................................ 38 
3.3 Study III ............................................................................................................... 38 
3.4 Study IV ............................................................................................................... 38 
4 The empirical studies .................................................................................................... 39 
4.1 Study I: Cognitive Behavioural Therapy and Return-to-Work Intervention 
for Patients on Sick Leave due to Common Mental Disorders: A 
Randomized Controlled Trial .............................................................................. 40 
4.1.1 Methods ................................................................................................... 40 
4.1.2 Results ..................................................................................................... 41 
4.1.3 Conclusions ............................................................................................. 42 
4.2 Study II: Internet-Based Cognitve BehavioralTherapy for Chronic Stress: 
A Randomized Controlled Trial .......................................................................... 43 
4.2.1 Methods ................................................................................................... 43 
4.2.2 Results ..................................................................................................... 44 
4.2.3 Conclusions ............................................................................................. 45 
4.3 Study III: Cost-Effectiveness of Therapist-Guided Internet-Based 
Cognitive BehavioralTherapy for Stress-Related Disorders: Secondary 
Analysis of a Randomized Controlled Trial ....................................................... 46 
4.3.1 Methods ................................................................................................... 46 
4.3.2 Results ..................................................................................................... 46 
4.3.3 Conclusions ............................................................................................. 47 
4.4 Study IV: The Mediating Role of Sleep in Internet-Based Cognitve 
BehavioralTherapy for Chronic Stress: Results from a Randomized 
Controlled Trial ................................................................................................... 48 
4.4.1 Methods ................................................................................................... 48 
4.4.2 Results ..................................................................................................... 48 
4.4.3 Conclusions ............................................................................................. 49 
4.5 Ethical considerations ......................................................................................... 49 
4.5.1 On the issue of random allocation .......................................................... 49 
4.5.2 Treatment side-effects ............................................................................. 50 
4.5.3 Handling of data ...................................................................................... 50 
5 Discussion ...................................................................................................................... 51 
5.1 Main findings ....................................................................................................... 51 
5.1.1 Treating stress-related disorders with CBT ............................................ 51 
5.1.2 Does CBT have an effect on work-related outcomes?........................... 53 
5.1.3 Can AD and ED be treated with the same protocol? ............................. 55 
5.1.4 Cost-effectiveness of ICBT .................................................................... 56 
5.1.5 Sleep as a putative mediator of change in ICBT .................................... 57 
5.2 General methodological issues............................................................................ 58 
5.2.1 Control conditions and follow-up ........................................................... 58 
5.2.2 Assessment procedures and measures .................................................... 59 
5.2.3 Generalizability ....................................................................................... 59 
5.3 From here on and forward ................................................................................... 60 
5.3.1 Regarding the effectiveness of CBT ....................................................... 60 
5.3.2 Regarding sick leave interventions ......................................................... 60 
5.3.3 What works for whom? ........................................................................... 60 
5.3.4 Dissemination and implementation ........................................................ 61 
5.3.5 Concluding remarks ................................................................................ 62 
6 Acknowledgements ....................................................................................................... 63 




LIST OF ABBREVIATIONS 
AD Adjustment disorder 
CBT Cognitive behavioral therapy 
CMD Common mental disorder 
COMBO Combined CBT and RTW-I 
DSM Diagnostic and Statistical Manual of Mental Disorders 
ED Exhaustion disorder 
ICBT Internet-based cognitive behavioral therapy 
ICD International Statistical Classification of Diseases and Related 
Health Problems 
ICER Incremental cost-effectiveness ratio 
ICUR Incremental cost-utility ratio 
ISI Insomnia Severity Index 
MMR Multimodal rehabilitation 
PSS Perceived Stress Scale 
RCT Randomized controlled trial 
RTW-I Return-to-work Intervention 
SMBQ Shirom-Melamed Burnout Questionnaire 
TAU Treatment-as-usual 
WLC Waitlist control condition 
WTP Willingness to pay 
 
  9 
1 INTRODUCTION 
Studying “stress” can be quite a stressful task if one wishes to grasp the full meaning of the 
concept. Where to begin? Stress is a commonly used word in our day-to-day language; one 
could ask any parent, teacher, nurse or neighbor and get a personal account, or just read about 
the deleterious consequences of stress in the daily newspaper. If a more scientific perspective is 
sought, there is an abundance of reading to do. Stress has been studied from many angles in the 
past century, across a wide range of fields. Definitions and theories vary, as do populations 
studied, terminology used, and outcomes measured. Models have placed varying emphasis on 
stress as “input” (i.e., what external events may act as generic stressors), “output” (i.e., the stress 
response, ranging from microbiological substrates of stress to its overt cognitive, emotional and 
behavioral expressions), and potential factors that interact with the experience of a stressful life 
event on the individual stress reaction (e.g., coping strategies, social support, self-esteem, or 
mastery). Clearly, there is a lot to learn and many who want to have a say in the matter.  
Working as a clinical psychologist in a primary care setting for over 10 years, I have been 
struck by the fact that there is so much knowledge about stress as a phenomenon, yet relatively 
limited research regarding how to best help individuals who suffer from prolonged or repeated 
exposure to stress. In stark contrast to what we know of treatment for many common mental 
disorders (e.g., depression, anxiety disorders, and insomnia), randomized controlled trials of 
interventions targeting stress-related disorders are few, and treatment guidelines rely largely on 
clinical experience and on findings from non-clinical populations. It seems the plethora of stress 
research, with different sample characteristics, methods and paradigms studied, has focused our 
attention on how to integrate findings and understand the wide array of terminology used, rather 
than develop efficacious treatments. Seeing the large proportion of patients who seek help in 
primary care for stress-related symptoms and disorders, the lack of evidence-based treatments 
has contributed to continued frustration for me and my colleagues (not to mention for the 
patients). We find that it is time for a shift of attention. 
In the present thesis, I will not attempt to give a comprehensive review of the different 
perspectives on stress and related research. Rather, I want to narrow the perspective to the field 
of clinical psychology and particularly to that of treatment. With the four papers presented in 
this thesis, I hope to provide a building block on which we can systematically accumulate 
evidence of interventions to alleviate suffering and increase functioning for the many 
individuals who are in need of treatment. My driving force is the provision of even-handed, 
gender equal, easily accessible and cost effective care for patients with stress-related disorders, 
as for all patients suffering from common mental disorders.  
 




2.1 STRESS AND STRESS-RELATED DISORDERS 
2.1.1 Definition of stress 
Today, most researchers within the field of psychological stress recognize that how individuals 
respond to life events and commonly identified stressors is the result of a complex interaction of 
individual traits (e.g., genetics, early childhood experiences, and personality), perceptions, 
lifestyle factors and the context in which the stressors occur [1]. In line with a transactional 
model of stress [2] and the allostatic load model [3], the work in this thesis is based on the 
conceptualization of stress as a continuous interaction between the individual and his or her 
environment. In short, “stress” is defined as the psychophysiological process that initiates when 
an individual perceives external demands to tax or exceed his or her resources at a specific time.  
Importantly, stress is not something negative by default. On the contrary, it is crucial to our 
survival and functioning in every day life. Our brains react to challenges (“stressors”) by 
activation of the autonomic nervous system, the hypothalamic-pituitary-adrenal axis, as well as 
the metabolic, immune- and cardiovascular systems. By the immediate release of chemical 
mediators by the brain (e.g., adrenaline and noradrenaline), the sympathetic nervous system 
contributes to increased blood pressure, heart rate, availability of energy to the muscles, and 
mental activity to help us effectively deal with the challenges (whether they be threats to our 
survival or running to catch a bus) [3]. This reaction in response to perceived stressors is often 
referred to as “acute stress” and is generally short-lived (minutes to hours). After the stressful 
situation, the parasympathetic nervous system restores the organism to a relaxed state by, for 
example, slowing the heart rate and decreasing muscle tension. The adaptive interplay between 
biological systems (such as the sympathetic and the parasympathetic nervous systems) that 
serves to maintain homeostasis in a changing external and internal environment, has been 
termed “allostasis” [4]. Figure 1 illustrates the many interacting components of stress, where 
allostatis and adaptation are central for our health.  
If allostasis is activated repeatedly or for long periods (in response to, for example, low-grade 
every-day stressors related to home and work life), the allostatic response may be insufficiently 
shut off between challenges. This can result in an overexposure to stress hormones (e.g., 
contributing to chronically elevated heart rate and blood pressure) and, over time, a 
dysregulation of the allostatic system [5]. The term “chronic stress” is often used to infer 
prolonged stress-reactions that last for several hours per day for weeks or months [6]. McEwen 
and collegues use the term “allostatic load” (see Figure 1) to mark the cumulative wear and tear 
that can result from chronically increased allostatis [3]. Allostatic load (or, chronic stress) can 
contribute to a range of pathophysiologic states, such as psychiatric, endocrine, and 
inflammatory disorders [7, 8]. 
  11 
 
Figure 1. A model of stress with the different interacting factors that may lead to chronic stress, or allostatic 
load. Reproduced (with permission from the author) from McEwen BS. Protective and damaging effects of 
stress mediators. N Engl J Med. 1998;338:171-179. Copyright © Massachusetts Medical Society 1998. 
In plain language, “adaptation” can be equated with recovery. Recovery refers to 
psychophysiological unwinding and stabilization after effortful expenditure, and incomplete 
recovery has been suggested to be an explanatory mechanism underlying the relationship 
between stress and chronic health impairment [9]. Our behavioral responses to perceived 
stressors can trigger a negative cycle of chronic stress in such a way that recovery, or 
adaptation, is aggravated. For example, many low-grade, chronically operating stressors may 
cause us to neglect seeing friends and minimize leisure time and physical activity. Further, we 
may decrease time for sleep, and increase intake of fatty foods, alcohol and nicotine. These 
behaviors, in turn, may affect our perceptions of threats and demands, and impede our ability to 
adapt to challenges in a resilient way.  
In summary, stress is natural and necessary as it allows for the accumulation of resources to 
meet, and adapt to, perceived challenges. Prolonged or repeated allostatic activation without 
adequate recovery, however, leads to a wear and tear of our biological systems and may 
conduce to changes in our perceptions, behaviors, and coping abilities that can ultimately lead 
to health impairment.  
In the following, I will use the term chronic stress when generally referring to the negative 
health consequences presumed to result from prolonged or repeated stress. Specific diagnostic 
terms for chronic stress such as adjustment disorder and exhaustion disorder (on which the 
studies in this thesis are based), are discussed below and will henceforth collectively be referred 




2.1.2 Stress-related disorders 
Chronic stress can lead to a range of clinical outcomes that cut across traditional boundaries of 
medical disciplines [7, 10, 11]. It can be difficult to demarcate stress-related disorders from 
other health conditions, not least to define them with clear-cut, specific criteria [12-15]. 
Nevertheless, our major diagnostic systems DSM-5 (Diagnostic and Statistical Manual of 
Mental Disorders, 5th edition) and ICD-10 (International Statistical Classification of Diseases 
and Related Health Problems, 10th edition) include sections dedicated to describing stress-
related disorders: Trauma and Stressor Related Disorders (DSM-5) and Reaction to Severe 
Stress, and Adjustment disorders (ICD-10). These sections include acute and prolonged 
reactions to traumatic stressors (acute stress reaction and post-traumatic stress disorder, PTSD), 
as well as reactions to non-traumatic stressors (adjustment disorders and, in the Swedish version 
of the ICD-10, exhaustion disorder – see below). Unspecific diagnostic terms are also included, 
such as “other specified trauma/stressor-related disorders” in the DSM-5 and “other reactions to 
severe stress” in the ICD-10. A common denominator of all stress-related disorders is that they 
should be directly related to a traumatic or stressful event (or a series of events) in such a way 
that it can be assumed that the disorder would not have occurred without experiencing the 
stressor. Also, it is the nature, pattern and duration of the symptoms, together with the 
associated dysfunction, that distinguishes the disorders [16, 17].  
Acute stress reaction and PTSD (i.e., reactions related to life-threatening or traumatic events) 
are beyond the scope of the present thesis, which rather focuses on reactions to the most 
common stressors. These are, at least in the western world, chronically operating, non-traumatic 
stressors such as difficulties at work, interpersonal conflict, and family or economic problems 
[18]. In my clinical experience from working in primary care, the majority of patients who seek 
help for symptom of stress, fatigue, anxiety, low mood, and/or disturbed sleep, struggle with 
this kind of stressors. Many do not meet criteria for a specific psychiatric or somatic disorder, 
and yet they experience a high level of distress and functional disability to a varying extent. For 
these patients, the diagnoses adjustment disorder (AD) or exhaustion disorder (ED) may be 
applicable. Table 1 gives an overview of the main diagnostic features of these disorders. In the 
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Table 1. Overview of the main diagnostic features of adjustment disorder and exhaustion 
disorder 
 
Adjustment disorder, F43.2  Exhaustion disorder, F43.8A  
   
Trigger One or many identifiable stressors One or many identifiable stressors 
Symptoms Emotional symptoms (anxiety, 
depressed mood) or behavioral 
changes 
Physical and psychological fatigue and:                                                
•      Impaired concentration/memory 
•      Intolerance to stress/time pressure  
•      Emotional lability and irritability 
•      Sleep disturbance                       
•      Bodily weakness                                   
•      Physical symptoms 
Impairment Significant distress or functional 
impairment in occupational, social, 
or other important areas of 
functioning 
Significant distress or functional impairment in 
occupational, social, or other important areas 
of functioning  
Time Symptoms within 3 months* after 
onset of stressor/s. Do not persist 
more than 6 months after termination 
of the stressor or its consequences 
Stressors present for at least 6 months. At least 
4 symptoms almost every day for at least 2 
weeks 
Note: Symptoms are not due to direct physiological effects of drug abuse or medication. If diagnostic criteria for 
other psychiatric or somatic disorders better explain symptoms, these diagnoses should primarily be used. 
*according to the DSM-5. 1 month according to the ICD-10. 
2.1.2.1 Adjustment disorder – diagnostic features 
The diagnosis AD can be used when an individual responds to stressful events with clinically 
significant disturbance in mood or behavior (e.g., anxiety, depressed mood, and/or impulse 
control problems) [16]. Stressors typically comprise non-traumatic events such as interpersonal 
conflict, work stress, divorce, illness, and socioeconomic difficulties. However, with an 
increasing number of refugees in the world, stressors related to forced migration, acculturation 
to a new culture, and economic hardship are also common [19]. The onset of the symptoms is 
within three months of exposure to the stressor(s) (one month according to the ICD-10), and 
tend to resolve within six months of termination of the stressor or its consequences [16]. If 
stressors are persistent or recurring (e.g., chronic disease or marital conflicts), AD may become 
chronic [16, 20]. Symptoms are clinically significant in that they are distressing and in excess of 
what could be expected of exposure to the stressor (taking into account contextual and cultural 
factors), OR in that there is significant impairment in social or occupational functioning. The 
DSM-5 specifies six subtypes of AD, each signifying the presence of specific symptoms: (a) 
depressed mood, (b) anxiety, (c) mixed anxiety and depressed mood, (d) disturbance of conduct, 
(e) mixed disturbance of emotions and conduct, and (f) unspecified [16]. The symptoms do not 
represent bereavement and are not of sufficient specificity or severity to justify another 










Over the years, the AD diagnosis has received a lot of critique pointing to (amongst other 
things) difficulties in differentiating the disorder from adaptive reactions to stress and from 
other mental health disorders [13, 19-22]. AD is sometimes referred to as a residual (“waste-
basket”) category for patients who do not meet diagnostic criteria for other psychiatric disorders 
[e.g., 13, 23, 24]. It is beyond the scope of this thesis to give an account of the debates 
surrounding AD. Importantantly, however, efforts have been made to improve the clinical 
utility of the condition. In the 11th version of the ICD (ICD-11), positive symptom criteria for 
AD have been established for the first time, relating to excessive preoccupation about the 
stressor or its consequences (for example, excessive worry, recurrent and distressing thoughs, or 
constant rumination about the consequences of the stressor). Further, AD subtypes have been 
removed in an attempt to build a more unifaceted diagnostic concept [e.g., 25].   
It should be noted that, although quite a few studies of AD based on the ICD-11 criteria have 
already been published, AD in the current thesis was defined based on criteria in DSM-4 (Study 
I) and DSM-5 (Study II, III and IV). Diagnostic criteria for AD in these two versions of the 
DSM are essentially the same, even though the DSM-5 reclassified AD to belong to the section 
Trauma- and stressor-related disorders.  
2.1.2.2 Exhaustion disorder – diagnostic features 
Because ED is a diagnosis unique to the Swedish ICD-10, a brief background to the diagnostic 
terminology related to chronic stress will be given before the disorder is described more 
specifically.  
As mentioned, in AD, symptoms usually subside within six months after the termination of the 
stressor(s). However, many times stressors are recurring or chronic in nature in such a way that 
symptoms may develop and exacerbate over the course of years (which is not unusual when it 
comes to, for example, relational conflicts or disease in the family). In cases where a person 
experiences chronic stress, symptoms of increasing fatigue, cognitive deficits, disturbed sleep, 
Linda is 36 years old. She is a generally healty woman, but the past few years 
have been rather taxing for her due to having three small children, working full 
time, and spending quite some time commuting to work. Four months ago, 
Linda’s oldest son was diagnosed with dyslexia. Since then, she describes feeling 
constantly anxious and tense. She has had a hard time relaxing and focusing on 
tasks at home and at work, struggeling with recurrent thoughts about how her 
son’s life will turn out, if he will get sufficient support at school… She has had 
frequent angry outbursts at her husband, which has led to many conflicts. Linda 
cries on a daily basis. She has difficulties falling asleep, and often drinks whine 
in the evenings to help calm herself.  
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and a range of somatic symptoms (e.g., pain, palpitations) are common [7, 10, 11]. When these 
symptoms do not clearly map onto established psychiatric or somatic disorders, however, there 
are large international inconsistencies regarding how they should be understood and 
categorized.  
If stressors are predominantly work-related, the term “burnout” is often used in the international 
literature [14, 26]. Burnout is thought to emerge as a prolonged response to chronic work-
related stressors [27], characterized by constant feelings of helplessness and exhaustion that are 
believed to represent the last stage of an adaptive breakdown [28]. Burnout has been defined in 
slightly different ways by different research groups over the years [29]. However, emotional 
exhaustion has remained a common core factor for the condition, indicated to be the most 
predictive of stress-related health outcomes such as headaches, chronic fatigue, gastrointestinal 
disorders, muscle tension, and sleep disorders [29]. Despite severe clinical implications, burnout 
is not a medical diagnosis in any diagnostic system and lacks diagnostic criteria.  
Another approach to define chronic stress-related conditions has been made by proposing 
criteria for allostatic overload [15]. These criteria postulate similar symptom development in 
response to chronic or recurring stressors as burnout (albeit not limiting stressors to the work 
context). Because the diagnosis is not included in the major diagnostic systems ICD or DSM, 
however, like burnout it holds limited clinical value to healthcare staff.  
The ICD includes the diagnostic term “reaction to severe stress” (F43.8), which is defined by 
symptoms of emotional stress, muscle tension, mixed disturbance of emotion and conduct, and 
psychomotor agitation [17]. Because the criteria are vague and lack, for example, any reference 
to time perspective regarding symptom development or functional impairment, the Swedish 
National Board of Health and Welfare suggested the term exhaustion disorder (ED) in 2003, in 
order to operationalize the clinical diagnosis and facilitate rehabilitation of the severe stress-
related condition commonly seen in clinical practice [30]. ED was accepted as a formal 
diagnosis in the Swedish version of the 10th revision of the ICD, accredited with the diagnostic 
code F43.8A.  
ED is characterized by symptoms of mental and physical fatigue (present for a minimum of two 
weeks) that are assumed to result from exposure to psychosocial stressors that have been present 
for at least six months before diagnosis. Core symptoms include markedly reduced mental 
energy, which is manifested by reduced initiative, lack of endurance, or an increase in time 
needed for recovery after mental effort. At least four of the ED symptoms specified in Table 1 
must be present nearly every day for at least two weeks, and lead to clinically significant 
distress or impairment [30]. Compared with AD, ED is by definition a more chronic and 
debilitating condition. However, as seen in Table 1, the diagnoses have important 
commonalities.  
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2.1.2.3 Natural course   
In a German population sample, Maercker et al. [31] found that, in 72% of people meeting 
criteria for AD, symptoms had developed in 6 to 24 months prior to assessment. There is 
empirical evidence to suggest that AD is a transient disorder from which most people remit 
spontaneously [32, 33]. However, studies indicate that there are subpopulations of AD in 
which symptoms increase over time and mark a trajectory toward a more severe disorder [34, 
35]. Five year follow-ups show that about 20% of patients with AD develop a psychiatric 
disorder, most commonly depression and alcoholism [36]. Both the DSM and the ICD 
recognize that AD can become chronic given persistent stressors, with symptoms present for 
up to two years [31].  
When it comes to ED, empirical evidence of disorder development and natural course is scarce. 
It seems, however, that ED entails a gradual increase in symptoms (e.g., infection, 
anxiety/depression, pain, fatigue) for which individuals repeatedly seek help in primary care 
years before a diagnosis of ED is set [37]. Based on clinical observations, the natural course of 
the disorder is often described as moving through different phases [30]: First, a “risk phase”, or 
a prodromal phase, may be observed, during which symptoms gradually accumulate in response 
to stressors and insufficient recovery. Second, an “acute phase” may accrue that often implies 
drastic cognitive difficulties, affective reactions and functional impairment, as well as anxiety 
related to ones own reactions. When the acute phase diminishes (usually after a few weeks), the 
third “recovery phase” begins. During this phase, depressive symptoms and anxiety tend to 
subside as daily activities and routines are resumed [38]. Some afflicted individuals may 
experience a heightened stress sensitivity and cognitive deficiencies that remain for years [39, 
40]. The clinically observed longitudinal course of ED and the severity of symptoms have 
amounted to sick leave recommendations of 6 to 12 months [41], which far exceed sick leave 
recommendations for other common mental disorders.  
2.1.2.4 Differentiatial diagnostics 
Because AD, according to the DSM-5, is in part defined by symptoms of depression and 
anxiety, it is sometimes difficult to distinguish this stress-related disorder from depressive 
disorders and anxiety disorders (specifically the unspecified forms, e.g., depressive disorder, not 
otherwise specificed). This is particularly the case when a depressive or anxiety disorder is 
precipitated by a stressful life event. As mentioned, according to the DSM-5, AD should be 
diagnosed only when symptoms are not sufficiently specific to justify another disorder, and 
when symptoms do not represent a deterioration of a previously existing mental disorder. For 
example, in the aftermath of a stressful life event, a patient may suffer from intense anxiety, 
recurrent worry, and bodily tension leading to functional disability. If symptoms are not specific 
enough to meet criteria for, for example, generalized anxiety disorder, AD can be diagnosed.  
Differentiating AD from depression can be particularly challenging [42]. If all diagnostic 
criteria for a depressive disorder are fulfilled and there is a known history of previous 
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depressive episodes, a diagnosis of depressive disorder should be set rather than AD, 
independent of whether the depressive symptoms were triggered by a stressful life event or not.  
Symptoms of anxiety and depression are also very common in patients with ED. In fact, in a 
study of 232 clinically referred patients with ED, 67% were assessed to also meet criteria for 
both depression and an anxiety disorder, 13% were diagnosed with depression only alongside 
ED, and 11% with a comorbid anxiety disorder [38]. With this large symptomatic overlap, 
determining which disorder should be the primary target of intervention can be difficult. 
Diagnostic guidelines state that ED should be set as a secondary diagnosis in cases when a 
patient also meets diagnostic criteria for depression or generalized anxiety disorder [30]. 
However, clinical observations suggest that, while depression is common during some phase of 
an ED, core symptoms indicative of ED (mental and physical fatigue, disturbed sleep, and 
cognitive deficiencies) often remain when the depression subsides [43]. Depression has been 
suggested to many times develop as a consequence or a complicating factor of ED, rather than 
vice versa [44].  
In my clinical experience, patients with ED often formally meet criteria for depression (for 
which the threshold is quite low), but differ somewhat in their clinical presentation with regard 
to symptoms. For instance, patients with ED may attest to depressed mood and diminished 
interest or pleasure sustained for two weeks (core criteria for depression) [16]. However, they 
commonly specify that the low mood is due to fatigue and that, even though the general interest 
in activities may remain intact, pleasure in these activities is diminished due to fatigue or 
cognitive difficulties. When assessing generalized anxiety disorder, patients with ED may, 
again, formally meet criteria. However, the content of the worry may differ from what is 
commonly seen in patients with generalized anxiety disorder. For example, patients with ED 
tend to worry about whether or not they will regain their previous capacity, or about the real life 
challenges with which they are faced (e.g., psychosocial difficulties, disease in the family, 
difficult work situations). The content of the worry is often understandable and rarely excessive. 
In contrast, worry content of patients with generalized anxiety disorder tends to be more 
miscellaneous and particularly characterized by minor, routine issues [45]. 
What about differentiating between AD and ED? These diagnoses share the presumed aetiology 
of identifiable life stressors as prerequisite for symptom development, and they share a putative 
longitudinal course of symptoms. Both AD and ED have large overlaps with depressive- and 
anxiety disorders [16, 30]. Although not empirically investigated, to my knowledge, it is 
plausible that AD and ED represent different clinical severity levels of stress, or allostatic load, 
on a continuum that ranges from adaptive, subclinical stress to chronic load reactions with 
severe functional disability. In this line of reasoning, it is conceivable that AD, in cases where 
stressors are chronic and symptoms enduring, may constitute a precursor to ED. In my clinical 
experience, patients with AD many times present with a clinical picture that suits well with the 
“risk phase” described in the presumed developmental course of ED (see section 2.1.2.3). 
Whereas diagnostic criteria for AD are quite broad and suggest a reaction within three months 
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of a life event, diagnostic criteria for ED are more specific and require stressors to have been 
present for at least six months.  
2.1.2.5 Prevalence 
Due to vague diagnostic criteria, differences in sampling, and lack of common diagnostic tools 
to assess AD, prevalence estimates of AD vary markedly between studies. Population based 
studies, using new diagnostic tools to assess ICD-11 AD, indicate a prevalence of around 1-2% 
in the general population [31, 46]. In clinical settings worldwide, however, AD is one of the 
most commonly used psychiatric diagnosis [47, 48]. Of studies conducted in the 1980s, a 
prevalence range of 11-18% was found in primary care settings, and 10-35% in consultation 
liaison psychiatry [49]. Similar estimates have been found in more recent studies, as indicated 
by a prevalence rate of 11.5% in outpatient psychiatric clinics in Kurdistan [50], and 9.2% in 
Swedish primary care [51]. Some studies indicate lower extimates, such as 2.9% of primary 
care patients in Catalonia [52].  
Because ED is a Swedish diagnosis, no large-scale epidemiological studies have been 
conducted and the prevalence of ED is largely unknown. Studies have found high levels of 
emotional exhaustion (assessed by self-report forms) in approximately 13-18% in the general 
Swedish population [53-55]. One study that investigated self-rated ED in a large sample of 
healthcare workers and social insurance officers found a prevalence of 16% [56]. Of patients in 
primary care, 30% reported symptoms that indicated ED (also by self-report questionnaire) 
[57]. Of note, self-rated symptoms of ED are not equivalent to the actual disorder, and hence the 
above mentioned estimates should be interpreted with causion. Symptoms of ED, such as lack 
of energy, disturbed sleep, difficulties remembering things or focusing attention, may be 
common to many somatic and psychiatric conditions, and careful clinical assessment regarding 
exposure to stressors, course of symptoms, and other potential psychiatric and somatic disorders 
are needed to set the diagnosis. A more representative prevalence estimate of ED amongst 
patients in primary care might be 9%, which was found in a study in which clinical assessment 
was conducted according to diagnostic criteria [58].  
2.1.2.6 Gender differences 
With few exceptions, the prevalence, incidence and morbidity rates of mental health disorders 
are higher in women than in men [59, 60]. There are indications that this pattern may hold true 
also for stress-related disorders. Statistics from the Swedish Social Insurance Agency indicate 
that, between the years 2010 and 2015, the increase in sick leave due to psychiatric disorders 
(predominantly stress-related disorders) was approximately four times higher for women than 
for men [61]. In some countries, women in the general population are diagnosed with AD over 
six times more often than men [62], and women are overrepresented amongst patients 
diagnosed with AD at psychiatric emergency care clinics [63]. In clinical trials of chronic stress, 
the proportion of female participants often exceeds 80% [64]. This being said, once a person has 
been diagnosed with a stress-related disorder, there seems to be no differences between the 
sexes when it comes to symptom severity or course of symptoms [38]. 
  19 
There are likely many explanations for the gender differences seen, such as differences between 
sexes when it comes to responsibility for home and family [65], and differences in help-seeking 
behavior. A recent report by the Swedish National Audit Office (2019:19) [66] indicated that 
general practitioners may play a role in the scewed sick leave pattern between men and women. 
According to the report, women with mild to moderate mental disorders receive sick leave 30% 
more often than do men, even though they are assessed to have the same limitations in activity 
and functional ability. Possible explanations proposed by the report include that women may 
have a more open attitude toward sick leave than do men, and that general practitioners may be 
influenced by certain gender norms. Also, the report suggests that general practitioners may 
overestimate work ability in men compared with women, and fail to recognize signals of mental 
ill health in men [66].  
A further elaboration on the topic of gender differences in stress-related disorders is beyond the 
scope of this thesis. The interested reader can get a short review of some theories put forth, for 
example the Rumination theory or the Gender role theory, as summarized in the article by 
Almeida et al. [67], the Biopsychosocial theory of stress presented by Frankenhaeuser [68], or a 
neurochemical explanation given by McEwen [69].  
2.1.3 Clinical correlates 
Chronic stress is associated with a range of adverse physiological and psychological outcomes. 
In the following, I will give an overview of some of the established clinical correlates.  
2.1.3.1 Mortality 
Chronic stress, specified as work-related exhaustion, has been found to predict all-cause 
mortality among industrial employees [70]. A Swedish study found that long-term sick leave 
due to a psychiatric disorder is associated with increased risk of mortality due to all causes 
(cardiovascular disease, cancer, suicide) [71]. This finding may be particularly pertinent to 
individuals with stress-related disorders seeing that they account for the longest sick leave 
periods in Sweden [72]. AD is associated with high suicidal ideation [73] and has been found to 
lead to higher rates of psychiatric morbidity, for example by suicide [74]. 
2.1.3.2 Cardiovascular disease 
There is a comprehensive body of research linking acute and chronic stress to cardiovascular 
disease [75, 76]. In a recent review, Kivimäki et al. [77] concluded that adults in the general 
population who experience stress in work or in private life have a 1.1 to 1.6-fold increased risk 
of stroke and incident coronary heart disease. A prospective cohort study found that the 
perception that stress affects ones health negatively can further increase the risk of coronary 
death or incident coronary heart disease, compared with those who experience stress but do not 
perceive the stress to be negative for their health [78].  
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2.1.3.3 Disorders of the immune system 
Whereas short-term, acute stress can enhance the immune system [79], chronic stress has been 
associated with immune dysregulation [80]. This is indicated by, for example, increased 
susceptibility to infectious diseases and chronic low-grade inflammation [81]. Further, chronic 
stress might influence immune function indirectly by modulating the adoption of health-related 
behaviors [81]. Stress-related disorders (including PTSD and acute stress reaction) have been 
shown to be associated with an increased risk of autoimmune disease [82] and subsequent life-
threatening infection [83]. This being said, research on specific biomarkers in samples with 
burnout or ED compared with healthy controls have generated conflicting results [84-87]. 
2.1.3.4 Cognitive impairments 
Associations between chronic stress and cognitive deficits have long been observed clinically. 
In particular, the prefrontal cortex (involved in, for example, controlling high-level executive 
functions such as working memory, novelty seeking and decision-making) and the hippocampus 
(involved in, for example, memory formation, learning, and spacial cognition) seem to be 
affected by chronic exposure to stress hormones, potentially resulting in dysfunction within 
these areas [88-92]. A systematic review of burnout and cognitive functioning concluded that 
executive functions, attention, and memory are the cognitive functions that are particularly 
affected by chronic stress [93]. Significant differences in scoring on neuropsychological tests 
have been found between patients with ED compared with healty controls [94, 95], and long 
term follow-ups indicate that cognitive impairments in these patients may be long-lasting [39]. 
Importantly, however, findings from cross-sectional studies using neuropsychological tests to 
compare clinical and non-clinical stress samples do not always yield consistent results [96], and 
no conclusions can be drawn with regard to causality.  
2.1.3.5 Psychiatric correlates 
Individuals suffering from chronic stress often struggle with depression [97, 98], anxiety [99, 
100], and insomnia [101, 102]. Whether or not any causal relationships exist between chronic 
stress and other psychiatric disorders is largely unknown. Some researchers suggest that there 
may be a progressive and dynamic relationship between stress and depression over time. For 
example, chronic stress might make a person more vulnerable to develop a major depression. 
When depressed, the person might, in turn, behave in ways that creates a greater vulnerability to 
exposure to further stressors, thus predicting recurrences of depression in a self-perpetuating 
cycle of depression and stress [97, 99]. Similar reciprocal relationships have been suggested 
between stress and anxiety disorders [99] and stress and insomnia [103, 104].  
2.1.4 Socioeconomic implications 
Chronic stress is associated with substantial individual suffering, and stress-related disorders are 
often related to frequent and long term sick leave [47, 72]. The high incidence of sickness 
absence for individuals with chronic stress, coupled with factors such as increased staff-
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turnover and extended usage of healthcare, implies high costs for employers and for society as a 
whole [105-107]. Furthermore, presenteeism (i.e., being present at work in spite of somatic or 
psychological illness, often resulting in reduced productivity) is a major cost-driver for chronic 
stress [106], indicated to reduce output by at least as much as absenteeism [108]. For the 
afflicted individual, chronic stress can lead to increased medical expenses and decreased income 
[106]. Total societal costs for work-related stress in western countries have been conservatively 
estimated to range between US $221 million to $187 billion annually [109]. Costs related to 
productivity loss have been found to be the largest contributors to the total costs, with direct 
medical and healthcare costs constituting remaining costs [109].   
2.1.5 Potential risk- and protective factors 
2.1.5.1  Childhood adversity and intrapersonal factors 
Adverse childhood environment and trauma can predict the onset of a range of adult psychiatric 
disorders [110, 111], and can affect afflicted individuals susceptibility to stress [112-114]. In a 
Swedish study, traumatic life events (both in childhood and in adulthood), post-traumatic stress 
disorder (PTSD), and attention deficit hyperactivity disorder (ADHD), were indicated to be 
significantly associated with burnout and long term sick leave due to stress [115]. Further, 
personality type characterized by high neuroticism has been found to moderate how effectively 
an individual copes with stress, and is associated with increased stress exposure, interpersonal 
conflict, and burnout [99, 116, 117]. Factors such as low self-esteem [34, 118], low self-efficacy 
[119], and perfectionism [120] have also been indicated to increase the risk of chronic stress. 
2.1.5.2 Work-related factors 
Work-related factors affecting stress and mental health have received a lot of attention in stress 
research. Two influential models are the job demand-control model [121] and the effort-reward 
imbalance model [122]. According to these models, high demands at work in combination with 
low control, or imbalance between personal effort and the rewards received for those efforts 
(e.g., job security, monetary rewards), are associated with high job strain (stress). A large body 
of research based on these models has established these work-related conditions (and the 
resulting job strain), as risk factors for mental health problems and cardiovascular disease [122-
125]. Studies have also found high demand-low control and high effort-low reward to be 
associated with burnout [126, 127] and symptoms of ED [128].  
2.1.5.3 Lifestyle- and behavioral factors 
Individual behavioral changes (e.g., down-prioritizing leisure time, social withdrawal, and 
excessive worry) have been identified as important in potentiating and exacerbating negative 
health outcomes due to stress [129-131]. In fact, a study of consecutively recruited adult 
patients in primary care indicated that lifestyle factors (e.g., exercise, sleep, social support, 
recovery, and self-care skills) explained significantly more of perceived stress than 
demographic factors (age, gender, employment, marital status, and education) [132]. In that 
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study, sleep and recovery showed the strongest inverse relationship with perceived stress 
[132]. This is in line with a large body of empirical research indicating that deficiency in 
recovery, including sleep, is a risk factor for the development of chronic stress and mental ill 
health [9, 131, 133].  
Recovery can be defined as the process of mental and physical deactivation, or unwinding, 
after an episode of effortful expenditure [9]. Recovery has been studied both in terms of 
extrinsic activities (e.g., watching TV, spending time with friends, and physical exercise) and 
in terms of intrinsic experiences of recovery (e.g., relaxation and being able to “switch off” 
thoughts about stressors) [131]. Rumination and excessive worry have been found to impede 
recovery by prolonging the effect of stressors, and thereby increase the risk of exhaustion and 
fatigue [134, 135]. A recently published study of a randomized controlled trial showed that a 
psychological intervention specifically aimed at increasing recovery activities in a sample 
suffering from chronic stress was effective in reducing symptoms compared with a waitlist 
control condition [136]. Further, a randomized controlled trial of an internet-based treatment 
for stress-related insomnia indicated that the waitlist-controlled improvement in sleep found 
in the treatment group was mediated by an increase in number of recovery activities that, in 
turn, was associated with lower perseverative cognitions [137].  
Besides recovery and sleep, physical activity and social support are are commonly suggested 
to compose protective elements in the development of chronic stress. For example, there 
seems to be an inverse relationship between leisure time physical activity on the one hand, and 
stress and life dissatisfaction on the other hand [138]. A prospective study in a sample of 
Swedish healthcare workers and social insurance officers found that physical activity can reduce 
the incidence of burnout [139]. Another study indicated that a 12-week aerobic training 
intervention in addition to a 24-week multimodal rehabilitation programme may have beneficial 
effects on episodic memory performance in patients with ED compared with those who 
received no aerobic training in addition to MMR [140].  
Social support, i.e., existing within a social context in which one experiences a feeling of 
belonging and support, is likely an important factor for mental health and quality of life in 
general [141]. Sheldon Cohen presented the “buffering hypothesis” based on the growing 
interest in the role of interpersonal relationships in protecting people against the possible 
adverse health effects of stressful life events. This hypothesis states that psychosocial stress is 
more likely to have deleterious health effects for those in lack of social support, whereas the 
effects of stress will be decreased for individuals with stronger support systems [142]. Even 
though empirical support of an interactive effect of social support on job stress is, in general, 
limited [124], some studies have found social support to mitigate perceived stressors [143] and 
reduce the risk of burnout [144]. A systematic review found that a lack of social support in the 
workplace was associated with more symptoms of ED and depression [128]. 
To summarize, many factors may interact to constitute risk- and protective factors in the 
development of chronic stress, including early life adversities, intrapersonal factors, work-
related factors, and a range of lifestyle and behavioral factors. In the following, lifestyle and 
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behavioral factors will be of primary focus, because these may be relevant in the maintenance of 
chronic stress, and often constitute main treatment targets in cognitive behavioral therapy 
(CBT). 
2.1.6 Maintaining mechanisms – a cognitive behavioral approach 
Although it is important to map risk factors in the development of chronic stress (not least to 
potentiate broad preventative measures), risk factors are imprecise when it comes to predicting 
exactly who will develop a stress-related disorder. As a complement to researching risk factors, 
cognitive and behavioral approaches have focused on increasing knowledge of what maintains 
psychopathology once it is established. To date, there is no single coherent and comprehensive 
psychological model with established empirical support for chronic stress. However, given the 
large overlap of chronic stress with anxiety and depression, it is plausible that chronic stress can 
be conceptualized within a similar framework to that which is used for anxiety and depression, a 
framework based on learning theory and/or cognitive information processing theory. In this 
section, I will give a brief account of these theories, followed by a proposed cognitive 
behavioral model for chronic stress.  
2.1.6.1 Learning theory 
Learning theory (which consists of a wide range of concepts and principles that will not be 
comprehensively described here) has the overall aim to explain learning processes. Two 
principals are of central importance: Respondent conditioning and operant conditioning. 
Respondent conditioning (sometimes called Pavlovian conditioning) refers to learning by 
association. For example, Linda experiences a high level of stress during a meeting with her 
employer, in which she is asked to complete a report until the next morning (she gets 
palpitations, breaks out in sweat, and feels dizzy). By respondent conditioning, previously 
neutral stimuli (such as the room in which they sit or the work clothes that Linda is wearing) 
may become conditioned to the eliciting stimulus and in themselves elicit a similar stress-
reaction at a later time [145]. In other words, Linda’s reaction may be generalized to situations 
or objects that previously did not elicit stress. With this type of generalized learning, exposure 
to stressors has the potential to increase exponentially (not only was the meeting stressful, but 
now Linda feels stressed about work the next time she puts on her work clothes), potentially 
resulting in repeated and and prolonged stress-reactions.  
Operant conditioning refers to learning by consequences. As proposed by B.F. Skinner (1902-
1990), our behaviors are, to a large degree, governed by whether they are positively or 
negatively reinforced or punished [146]. Reinforcement increases the likelihood of a behavior 
by means of reducing an aversive experience (negative reinforcement) or by increasing a 
desired experience (positive reinforcement). Continuing with the example above: After the 
meeting with her employer, Linda decides to work late and cancels her evening plans. Her 
stress-reaction subsides quickly (negative reinforcement), and she feels pride in that she is a 
trusted employee that is able to problemsolve effectively (positive reinforcement). The 
consequences of Lindas behavior increase the likelihood that she will behave in a similar 
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manner the next time she is asked to meet a difficult deadline. Although beneficial in the short 
run, operant behavior can prohibit new learning experiences (such as investigating what would 
happen if she declared that the deadline was too short, if she asked for help, or simply refused). 
Respondent and operant learning interact and perpetuate each other, and, in the long run, 
influence lifestyle choices that may cause negative health consequences.  
2.1.6.2 Cognitive information processing theory 
Whereas learning theory broadly speaking concerns how contextual factors govern behavior, 
cognitive theory focuses on the role of mental processes, such as attention, memory, perception, 
and problem solving, in affecting our emotions and behaviors. This is evident in the 
transactional model of stress, for example, which posits that it is the individuals perception of a 
threat or stressor that affects the emotional response and leads to a range of behaviors – not 
necessarily the stressor in and of itself [2]. When Linda is asked to complete a task at work, for 
example, her automatic cognitive response is “I must do an excellent job” and “If I fail my boss 
she will find out that I am a looser and I may get fired”. These thoughts play a significant role in 
Linda’s emotional reaction and behavior. Clearly, perceptions and interpretations are not always 
“correct” when it comes to evaluating a threat and anticipating events. When a person is 
experiencing high stress, anxiety, or depression, information processing can become biased 
[147, 148]. When under stress, for example, attention may be directed towards further threats, 
and it becomes increasingly difficult to sort and evaluate impressions [149, 150]. 
In summary, a cognitive behavioral approach to chronic stress implies that both dysfunctional 
behavioral patterns and biased information processing play a role in the development and 
maintenance of symptoms.  
2.1.6.3 A proposed CBT model for chronic stress 
Taking a cognitive behavioral approach to chronic stress points to the importance of analyzing 
contextual factors of behaviors and thoughts that are incompatible with recovery, and of 
analyzing dysfunctional avoidance behavior that may reduce the individual’s resources to 
handle demands. Figure 2 presents a model of the maintenance of chronic stress, as proposed by 
Niclas Almén [151]. The model illustrates how thoughts, emotions, physiological reactions, and 
behaviors intimately interact and maintain chronic stress once symptoms have already 
accumulated. Importantly, these maintaining factors often differ from the factors that were 
central in the initial development of chronic stress. Hence, symptoms may not subside 
automatically even if the initial stressors are removed.  
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Figure 2. Maintaining model of chronic stress, adjusted and translated with permission from Niclas Almén [151].  
Let us look at an example for clarification. John struggled with high job demands for an 
extended period (several months), while also having small children at home that needed care 
after working hours. His every day life was full of potential stressors with limited room for 
recovery. He successively experienced increased tension, disturbed sleep, and fatigue (which, 
under the circumstances, would be considered normal). These symptoms, in turn, became 
stimuli for new stress-reactions. At work, for example, John noticed that he had a hard time 
focusing, and tasks took longer to complete. Not performing at his regular high capacity 
triggered worry and a feeling of inadequacy. To cope with this, he cut out breaks at work, and 
opened the computer at home in the evenings to complete what he had not finished. While this 
temporarily reduced his stress (negative reinforcement), Johns new habits made it more difficult 
for him to fall asleep. He struggled with perseverative rumination about his life and how he 
should handle his job. Lying in bed ruminating made John feel that he was actively trying to 
solve the situation (positive reinforcement). However, increasing fatigue made it more difficult 
for him to engage in his family, which led to conflicts with his wife (an additional stressor). 
John began to stay late at work to avoid his wife and the negative emotions evoked by their 
arguments (negative reinforcement).  
Ironically, John’s reaction to his situation and his symptoms led to a negative spiral of more 
symptoms and less recovery. As is common in patients with anxiety and depression, John 
engaged in behaviors to alter, avoid or control his emotional responding rather than adaptive 
strategies to deal with the stressful situations [152]. Previous recovery activities, such as taking 
a lunchbreak with collegues, going to the gym, spending time with family and friends, or 
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watching a movie at night, came to be directly punished in that they increased Johns feelings of 
inadequacy, physical tension, and biased cognitions (e.g., “If I take a break I won’t finish work 
on time and they will think I’m a slacker”). 
In summary, emotional, cognitive, and behavioral responses to chronic stress often perpetuate 
each other and maintain symptoms by further obstructing recovery. Once this chain of events 
has begun to live its own life, removing external stressors (by, for example, sick leave) can be a 
necessary, but often insufficient, solution for symptom reduction. The model proposes that 
interventions targeting the cognitive and behavioral responses to chronic stress may be helpful 
in breaking the chain of increased stress-exposure, deficits in recovery, and health-damaging 
behavior.  
2.2 COGNITIVE BEHAVIORAL THERAPY 
Cognitive behavioral therapy (CBT) is an umbrella term for psychological treatments that are 
based on learning theory and/or cognitive psychology. CBT specifically targets patterns of 
unhelpful behaviors and ways of thinking, and has the overarching treatment goal of improving 
functioning and achieving symptom reduction by helping patients to alter dysfunctional 
cognitions and maladaptive behavioral patterns [153]. To date, CBT is by far the most 
rigorously researched psychological treatment method for a range of mental disorders, with 
meta-analyses of randomized controlled trials yielding large effect sizes in the treatment of 
anxiety disorders [154], depression [155], and insomnia [156].  
Meta-analyses indicate that CBT may also be a promising treatment method to reduce stress in 
the working population [157-160]. However, as pointed out by the authors of these meta-
analyses, most interventions are applied on a general population of employees rather than on 
those in need (i.e., that are clinically referred or suffer from high levels of stress and burnout). 
Indeed, CBT for clinical populations suffering from chronic stress or stress-related disorders has 
been significantly less studied. Three meta-analyses [64, 161, 162] and one systematic review 
[163] have evaluated the effect of interventions (mainly CBT) for chronic stress or stress-related 
disorders. These found no significant effect on symptoms compared with control conditions, but 
reported low confidence in results due to the limited number of studies eligible for inclusion, 
limitations in methodological quality of studies, and heterogeneity of studies with regard to 
treatment content, length, extent, and type (individual or group) of interventions.  
In summary, although there is evidence to suggest that CBT can be effective in reducing 
anxiety, depression, insomnia, and stress, there are important knowledge gaps regarding 
whether CBT is effective in reducing symptoms in populations suffering from chronic stress in 
general and stress-related disorders in particular. 
2.2.1 Common treatment techniques and protocols 
Before we move on to reviewing studies of CBT for chronic stress, I want to present some 
common treatment techniques included under the CBT umbrella, and present the form and 
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content common to CBT protocols for chronic stress (including the protocol used in the present 
research project). 
2.2.1.1 Behavioral activation 
Behavioral activation is a brief, goal-directed and activating treatment, originally developed for 
patients with depression [164]. The goal of behavioral activation is to improve mood by means 
of decreasing negatively reinforced avoidance behavior and increasing behavior that is 
positively reinforced [165]. Because avoidance and reduced value-driven behavior (i.e., 
behavior that is in line with what is intrinsically important to an individual) is common to many 
mental disorders (not only depression), behavioral activation has been suggested to be broadly 
integrated into psychotherapy [166], also for patients with AD [167]. In a study investigating 
burnout-depression overlap in schoolteachers, the authors concluded that treatment for 
depression may be helpful for individuals identified as “burned out” [168].  
2.2.1.2 Exposure 
Exposure is a therapeutic technique to enable new learning by means of systematically 
approaching feared stimuli (internal, such as thoughts, feelings and physiological responses, and 
external, such as physical places and objects) in the absence of the associated aversive event. 
Building on Linda as an example, she comes to a point where she is afraid to go to work 
because she thinks she would collapse (which happened on a previous occation). The workplace 
has become a conditioned stimulus associated with fear. Exposure would imply repeatedly 
approaching the workplace, learning that the workplace in itself does not cause a collapse. 
Although it is unknown exactly how exposure excerpts its effect, research suggests that the 
conditioned response (e.g., fear) may not be completely extinguished. Rather, by means of so 
called inhibitory learning, the conditioned stimulus (e.g., the workplace) continues to be 
associated with fear on the one hand, but also with safety [169].  
Exposure therapy has been shown to be an effective treatment strategy for anxiety disorders 
[154], and given that anxiety is common in patients with stress-related disorders, it is plausible 
that patients with stress-related disorders could also benefit from this therapeutic technique. 
Examples of specific stress-related fear- and avoidance patterns that could be helped by 
exposure are: Fear of making a mistake or of not performing as well as usual (perfectionism), 
fear of assertiveness (e.g., stating ones mind or turning down an offer), or fear of symptoms. 
Fear of symptoms or health deterioration is common in patients with stress-related disorders and 
feeds avoidance of activities and behaviors that may be health promoting, such as physical 
activity, making an appointment, or meeting with a friend.  
2.2.1.3 Cognitive restructuring and behavioral experiments 
Cognitive restructuring is a technique based on information-processing theory, with the aim to 
affect obstructive emotions and symptoms by means of cognitive reappraisal. Cognitive 
reappraisal is achieved by identifying dysfynctional beliefs and thoughts that are believed to 
maintain emotional distress, and then to challenge these beliefs to generate more functional 
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thinking patterns [148]. For example, Linda holds the belief that “If I go to work I will surely 
collapse, and everybody at work will think that I am weak and laugh at me”. By investigating, 
for example, the likelihood of this aversive event, and what would be the worst thing that could 
happen if the aversive event occurred, Linda might reappraise her belief and subsequently 
decrease her fear.  
One common way of challenging dysfunctional thoughts is by conducting behavioral 
experiments. Behavioral experiments imply that a person explicitly tests target cognitions by 
confrontation with anxiety-provoking situations [147]. In the example of Linda, she might visit 
the workplace to find out whether or not she collapses. She might experiment with showing 
weakness at work (such as faking a collapse or talking about her health problems) to investigate 
how her collegues react to her (do they laugh?).   
2.2.1.4 Form and content of common face-to-face CBT protocols for chronic stress 
Both group CBT [170-179] and individual CBT [170, 180-186] have been evaluated for chronic 
stress. Group interventions tend to vary greatly in length, with a range of between 8 to 30 
sessions spread over a period of 8 weeks to 1 year. In general, each session lasts for about 2-3 
hours and includes between 6 to 12 participants. Individual CBT interventions comprise 
approximately 6 to 10 hours total treatment time, spread over 5 to 16 weeks. Whereas many 
interventions are administered by psychologists or psychotherapists, other professional 
categories are also used, such as “labor experts” [180], “stress-management consultants” [171], 
and occupational physicians [186].  
Treatment content is quite similar to what is commonly found in protocols for stress-reduction 
in non-clinical samples (see, for example, [157]). All protocols include psychoeducation about 
stress. Most often, cognitive restructuring is the main techniques used, coupled with, for 
example, time-management or problem solving skills, lifestyle interventions (e.g., establishing 
daily routines or promoting physical activity), communication skills training, and some kind of 
relaxation strategy. Generic CBT techniques such as behavioral activation and exposure are 
rarely employed, at least not explicitly. For example, although some protocols express having 
an “activating approach” (which is equated with graded exposure) [180, 186], I have found only 
two studies that specifically mention including exposure techniques in the treatment [172, 178].  
When a primary aim of the intervention is to support sick-listed patients back to work, specific 
components are often included in the CBT for this purpose. Interventions include identification 
of obstacles for return to work, gradual increases in working hours, and optional meetings with 
employers [179, 180, 182, 184, 186]. Some studies investigate multidisciplinary treatment 
approaches and add interventions alongside CBT, such as qigong [179] and mindfulness-based 
stress-reduction [184].  
2.2.1.5 Multimodal rehabilitation  
Multimodal rehabilitation (MMR) is a complex intervention with the aim to provide 
rehabilitation and improve functioning in those with chronic health conditions. MMR consists 
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of varying interventions delivered by different health professional categories, and usually 
incorporates group treatment (based on CBT) given parallel to, for example, physical activity, 
vocational rehabilitation and, potentially, antidepressant treatment [30, 64, 187]. In Sweden, 
MMR is the recommended treatment for ED [30], even though evidence of the effectiveness of 
this type of extensive and costly treatment program is limited. As pointed out in a recent 
narrative review, the interpretation of MMR studies is complicated by the fact that it is not a 
uniform concept and can include a range of different treatment modalities [187].  
2.2.1.6 The protocol used in this research project 
The CBT protocol used in the studies included in this thesis has been developed over years of 
clinical practice at Gustavsbergs primary care clinic in Stockholm, Sweden. A basic assumption 
of the treatment is that stress is a natural and necessary part of life, but that negative health 
consequences may result from insufficient recovery in combination with maladaptive behaviors 
adopted in response to sustained stress (see section 2.1.6.3). Independent of symptoms and 
functional ability, a goal of the treatment is to support patients in developing a daily balance 
between effortful expenditure and recovery, in order to improve coping capacity and support 
patients in becoming active agents in their own lives. Table 2 summarizes the treatment 
components, as well as the main exercises worked with throughout treatment. Although the 
treatment incorporates both cognitive and behavioral components, it is primarily behaviorally 
oriented. 
The treatment begins with psychoeducation about acute and chronic stress, as well as common 
behavioral patterns that may maintain symptoms. It is important to explain and normalize 
psychological and physiological reactions, because studies have shown that negative beliefs 
about stress can predict somatic symptoms and moderate the affective response to real life 
stressors [78, 188, 189]. 
The treatment then moves on to target deficits in recovery by encouraging identification and 
scheduling of idiosyncratic recovery activities, as well as by introducing a short relaxation 
exercise. As a means of supporting recovery, one session is dedicated to giving 
psychoeducation about sleep [190] together with empirically supported interventions for 
improved sleep (sleep hygiene and stimulus control) [156, 191]. 
The next step in the treatment involves work to identify central life values (i.e., what kind of a 
person do I want to be, and what is genuinely important to me?) within different areas of life 
(e.g., relationships, leisure time, occupational). Values constitute the motivational basis from 
which behavioral repertoires can successively be adapted to include more positively reinforcing 
and health promoting behaviors. From module 4 and onward, the treatment essentially 
incorporates the brief behavioral activation treatment for depression (BATD) as developed by 
Lejuez and collegues [165]. Additionally, exposure techniques [192] are taught in module 6 to 
help patients deal with difficult emotions and impulses that may arise when working with 
behavior change, and break fear-avoidance patterns related to, for example, assertiveness, 
perfectionism, and excessive worry.  
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Table 2. Overview of treatment content in CBT for stress-related disorders 
Module Theme Main exercises 
1 Introduction to CBT and psychoeducation 
about stress 
 
2 Learning recovery techniques and practicing 
relaxation 
 
3 Dealing with disturbed sleep   
4 Identifying values and breaking them down into 
concrete activities/behaviors 
 
5 Behavioral activation, taking steps  
6 Exposure, dealing with difficult emotions, 
breaking fear-avoidance patterns 
 
7 Continued behavior change toward life balance 
and health 
 
8 Continued behavior change toward life balance 
and health 
 
9 Identifying and challenging core cognitive 
assumptions 
 
10 Communication skills, assertiveness training   
11 A summary of the treatment  
12 Maintaining gains and relapse prevention  
CBT, Cognitive behavioral therapy 
Towards the end of the treatment (modules 9 and 10) core cognitive assumptions (i.e., insistent 
beliefs about, for example, how one should behave to be socially accepted) are identified. Such 
assumptions have likely been helpful during other periods in life, but for patients suffering from 
chronic stress they may maintain behavioral patterns that obstruct recovery and desired 
behavioral change. Strategies for helpful communication when under stress are taught and 
practiced. These include strategies for self-assertion (i.e., clearly communicating ones needs or 
opinions), strategies for giving and receiving critique, and listening to another person.  
Through self-monitoring and work with functional analyses throughout the treatment, patients 
identify their own maladaptive stress-related cognitions and behavioral patterns that are 
believed to maintain symptoms of chronic stress. They are encouraged to plan their days to 
include a variety of effortful activities, value-driven activities, and recovery activities. Upon 
completing the treatment, patients create a plan to maintain gains and prevent relapse. 
In the current research project, the treatment was evaluated both as an individual face-to-face 
treatment and as an ICBT. In both formats, modules were presented in a consequtive order and 
patients had weekly communication with their therapists (licenced clinical psychologists). In the 
ICBT, therapists and patients communicated exclusively via the treatment platform, and 
because treatment content was conveyed through text in the platform, communication mainly 
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Of note, upon converting the treatment from the face-to-face protocol to the internet platform, 
two sessions were added (modules 7 and 8 in Table 2). These included no new information but 
were designed to further support patients in working with the behavioral changes that were 
identified as important in the previous modules.  
2.2.2 Randomized controlled trials of face-to-face CBT 
In this section I will give an overview of the existing evidence for face-to-face CBT for chronic 
stress and stress-related disorders. The studies reviewed are exclusively randomized controlled 
trials of adult, clinical populations (i.e., participants have undergone clinical assessment and are 
not recruited solely based on elevated symptom levels on a self-rating scale). 
2.2.2.1 Treatment effect on symptoms 
In most studies, CBT has been found superior to waitlist control conditions pre- to 
posttreatment [175, 176, 178, 184, 185]. Studies that have compared CBT with “no treatment” 
control groups (in which patients were clinically assessed and then free to seek other help), 
however, have generated mixed results: One study indicated that CBT was significantly 
superior to no treatment [183], but two studies found no differences between groups regarding 
symptom reduction [181, 182]. Of note, in these studies approximately half of patients in the 
control groups received psychological treatment outside of the studies.  
Studies that have explicitly compared CBT with other active treatments and/or treatment-as-
usual (TAU), have generated a rather consistent pattern of findings: Symptoms have reduced in 
all treatment arms over time, but no significant interaction effects have been found (i.e., there 
appears to be no specific effect of CBT) [170, 173, 177, 179, 184]. This was the case when, for 
example, cognitively oriented group CBT was compared with psychodynamic group therapy 
and with TAU [173], when CBT (including work place interventions) with added qigong was 
compared with qigong only [179], and when CBT was compared with a work-focused CBT 
and TAU [180]. When a multidisciplinary treatment including CBT, work-place dialogue, and 
mindfulness-based stress-reduction was compared with TAU (12 conventional, individual 
sessions with a psychologist) and a WLC, the treatment was no more effective than TAU, but 
both CBT and TAU were more effective than the WLC in reducing symptoms [184].  
There are some exceptions to the pattern described above. When group CBT was compared 
with a physical activity intervention and TAU, CBT was found to be more effective than 
physical activity in improving general health in patients (even at the 6- and 12-month follow-
ups), and also in reducing burnout ratings pre- to posttreatment compared with TAU [171]. 
However, on all other outcomes (of note, no primary outcome was reported) no significant 
differences were found between groups. In a study in which CBT was compared with a placebo 
group intervention for sick-listed men, CBT was found to be significantly more effective on all 
symptom domains pre- to posttreatment [172]. 
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It is difficult to interpret and draw conclusions from the relatively limited number of 
randomized controlled trials that have been conducted of CBT for chronic stress. Studies use 
differently defined populations, different outcome measures (rarely specifying a primary 
outcome), and different treatment approaches (e.g., “Work-focused CBT”, or multidisciplinary 
treatment programs of which CBT is a part). Further, several methodological issues limit 
conclusions. For example, studies using three treatment arms tend to include small sample sizes, 
thus limiting power to detect true differences between interventions [170, 171, 173, 177]. Some 
studies suffer from substantial attrition [170, 173, 179], from low treatment adherence, and from 
the fact that patients to a large extent receive treatment outside of the study [e.g., 179, 182-184].  
2.2.2.2 Treatment effect on sick leave 
Because chronic stress is often defined, in part, by inability to work (i.e., sick leave), and a 
majority of studies require sick leave for inclusion [171, 173, 179, 182-184], days on sick leave 
or rate of return to work is often a central outcome in randomized controlled trials of face-to-
face treatment for chronic stress. Evidence of the effect of CBT on sick leave for individuals 
with chronic stress is mixed. Some studies have found interventions based on CBT principles to 
facilitate return to work or lead to full work resumption faster than control conditions [184, 186, 
193]. Others, however, have not [170, 183]. In a study by Blonk and colleagues [180], an 
intervention administered by labor experts that combined CBT principles with interventions 
targeting increased work resumption was found to reduce time to partial and full return to work 
compared with only CBT. Willert and colleagues found that CBT compared with a waitlist 
control was effective in reducing self-reported absenteeism, but registry-based data on sick 
leave did not show significant differences between groups [194].  
In a Cochrane Review of interventions to facilitate return to work in adults with AD, authors 
found moderate quality evidence that CBT did not reduce time to partial or full return to work 
compared with no treatment [162]. However, interventions directly aimed at supporting return 
to work by means of problem solving (often based on CBT-principles) were found to 
significantly enhance partial return to work at 1-year follow-up compared with non-guideline 
based care [162]. A recent meta-analysis of tertiary interventions for chronic stress found a 
significant overall effect of CBT on partial return to work compared with controls [64]. One 
meta-analysis of psychological interventions (including CBT) for CMDs (including stress-
related disorders), found a small but significant effect of treatment on sick leave [195]. In this 
meta-analysis there were no differences in effect between interventions with a primary aim of 
reducing symptoms and those which aimed directly at supporting return to work [195].  
2.2.2.3 Summary of evidence base 
In summary, research on CBT for chronic stress and stress-related disorders is limited and 
results are mixed. The lack of internationally congruent diagnostic terms and assessment 
procedures, heterogeneity in interventions and outcomes, and methodological limitations, 
makes it difficult to interpret results and draw conclusions about the effect of CBT for patients 
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with stress-related disorders. More adequately powered, methodologically sound randomized 
controlled trials are needed.   
2.2.3 Therapist-guided internet-based CBT 
There is a high demand for CBT amongst patients with mental health problems, but access to 
treatment is generally limited [196]. To overcome the gap between demand and access, 
delivering treatment via the internet has emerged as a viable option over the past 20 years [197]. 
The main idea of therapist-guided internet-based CBT (ICBT) is to help individuals accomplish 
the same cognitive- and behavioral changes as with conventional CBT, but treatment content is 
delivered via the internet by means of self-help texts and other multimedia tools. In ICBT, 
patients generally communicate with their therapist weekly throughout the treatment by 
asynchronous, email-like text messages in the treatment platform. However, studies have 
increasingly investigated different forms for therapist support, such as only providing support 
upon the request of the participant (so called adherence-focused support) [198, 199]. Self-
guided internet-based treatments (i.e., with no therapist support except for, perhaps, technical 
support) have also been investigated [200-202], but most studies point to the importance of 
therapist support for treatment effectiveness [203, 204] as well as for optimizing adherence and 
preventing drop out [205, 206]. 
ICBT has been shown to be efficacious for anxiety disorders [207, 208] and depression [207, 
209], and is indicated to be equally effective as face-to-face CBT in treating these conditions 
[210, 211]. Because ICBT often requires less than 10 minutes of therapist time weekly per 
patient [197], ICBT can be a resource efficient alternative to face-to-face CBT, with additional 
benefits including increased availability of treatment to patients in rural areas, and that patients 
can access the treatment outside office hours.  
2.2.3.1 What do we know about ICBT for chronic stress? 
The short answer to this question is: Not very much. When it comes to ICBT for stress-
reduction, significantly less research has been carried out compared with face-to-face CBT. 
Even so, two meta-analyses and one review have been conducted of web- and computer-based 
interventions to reduce stress, jointly pointing to a potential positive effect of ICBT in reducing 
stress in heterogeneous samples [204, 212, 213]. Whereas the meta-analysis conducted by 
Stratton et al. [213] included interventions for a broad range of mental health problems in 
employees, Heber et al. [204] specifically investigated the effect of interventions aimed at 
reducing stress. In that meta-analysis, ICBT was found to reduce level of perceived stress with 
small to moderate effect sizes compared with waitlist control conditions. Interventions generally 
lasted between 6 and 12 weeks, and were most often self-guided. Many of the included studies 
had a high risk of bias and there was moderate heterogeneity between trials [204]. Of note, 
however, some individual studies with high methodological rigor investigated the effect of 
ICBT for stress-reduction in employees with elevated levels of stress, generating large effect 
sizes on symptoms of stress and significant effects on a range of secondary mental health 
outcomes [198, 200, 214].  
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As is the case for most studies of face-to-face CBT for stress-reduction, samples studied in trials 
of ICBT are often unselected, non-clinical (or with elevated symptoms as assessed by self-rating 
scales), and have rarely undergone formal assessment with respect to somatic and psychiatric 
morbidity. Hence, although there are promising indications of ICBT for stress-reduction, 
generalizability of findings to those suffering from chronic stress or stress-related disorders may 
be limited.  
I have found only two randomized controlled trials that have investigated ICBT for clinical 
samples of chronic stress. In one of the studies, the effect of a brief (four modules) CBT based 
on relaxation, time management, mindfulness, and strategies to cope with interpersonal 
difficulties, was compared with a waitlist control condition for individuals with AD [215]. AD 
was determined using a self-rating scale to assess the ICD-11 diagnostic criteria. Participants 
had full access to modules and the intervention was completely self-guided. In that study (N = 
284), 52% of participants never completed a single excersise, and 86% of participants failed to 
complete follow-up assessment. Hence, although a completers-analysis indicated a moderate 
waitlist-controlled effect size on AD symptoms in the intervention group, no firm conclusions 
can be drawn regarding the efficacy of the intervention. The second study tested the efficacy of 
ICBT for a clinically assessed sample of managers diagnosed with any condition included in the 
section F43 Reaction to severe stress, and adjustment disorders in the ICD-10 (including ED). 
The treatment content was somewhat similar to that of the ICBT investigated in the present 
thesis (see section 2.2.1.6). Results indicated that the intervention generated large effects on 
symptoms of stress and exhaustion compared with an attention control group, and effects were 
maintained at a 6-month follow-up [216]. 
As for sick leave, no ICBT study aimed at reducing stress has, to my knowledge, assessed sick 
leave objectively (i.e., by use of registry data). Work-related outcomes are sometimes addressed 
in terms of, for example, self-rated absenteeism and presenteeism. On these outcomes, most 
studies have found no effect of ICBT compared with waitilist control conditions [198, 214, 
216]. An exception was in the study by Ebert et al. [200] in which self-guided internet-based 
stress-management was found to produce a small but significant effect on presenteeism six 
months after treatment completion.  
In summary, although ICBT is indicated to be efficacious in treating many mental disorders, 
and is likely efficacious in reducing stress in mixed samples, more large scale randomized 
controlled trials are needed to test the efficacy of ICBT for clinical samples diagnosed with 
stress-related disorders. 
2.2.4 Health economic effects 
Health economic evaluations are important to provide decision makers with information about 
which treatments give maximum effect in relation to their cost [217]. Without knowledge of 
cost-effectiveness, there is a risk that healthcare resources are used inefficiently, and that fewer 
can be offered treatment [218]. The question of costs in relation to effects may be of particular 
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importance when it comes to treatment for ED, given that the recommended multimodal 
rehabilitation programs imply high costs and lack evidence of effectiveness [219].  
Two common forms of health economic analyses are cost-effectiveness and cost-utility 
analyses. Cost-effectiveness concerns the association between costs and disease-specific effects 
(such as remission rates), whereas cost-utility concerns the association between costs and more 
general outcomes that are meaningful regardless of clinical condition (such as health-related 
quality of life). To estimate cost-effectiveness and cost-utility, incremental cost-effectiveness 
ratios (ICERs) and cost-utility ratios (ICURs) are usually calculated. ICERs and ICURs are the 
difference in costs between two conditions, divided by the difference in condition effect (i.e., 
remission rates or health-related quality of life, respectively) [217]. Analyses can be conducted 
from the perspectives of different stakeholders, such as society, the healthcare system, or the 
clinic. Because the amount of money a decision maker is willing to pay for, for example, one 
additional patient in remission, it is crucial in determining whether a new treatment is to be 
adopted or not, cost-effectiveness and cost-utility are usually expressed in terms of different 
willingness to pay (WTP) scenarios.  
Although there are indications that work-site mental health interventions for stress-reduction 
may yield a positive cost-benefit ratio (i.e., monetary benefits, not in relation to clinical 
outcomes), health economic studies of interventions aimed at reducing stress generally suffer 
from low methodological quality, and evidence of cost-effectiveness and cost-utility is lacking 
[220]. I have found only two health economic evaluations of internet-based interventions aimed 
at reducing stress in employees with elevated work-related stress [221, 222]. Both of these 
studies indicated that the interventions had approximately 70% probability of being cost 
effective compared with waitlist control conditions, from an employer’s perspective [221] and 
from a societal perspective [222], at a WTP of 0. Although these results are promising, to the 
best of my knowledge, no study to date has conducted a health economic evaluation of CBT (or 
ICBT) for patients diagnosed with AD or ED. 
2.2.5 Mediators of change 
Although CBT is indicated to be effective in reducing stress and stress-related symptoms (see, 
for example, [157]), there are to date large knowledge gaps regarding what factors in treatment 
contribute to bringing about these changes. The mixed results found across studies investigating 
CBT for chronic stress suggest that not all patients are sufficiently helped, and that there is 
substantial room for improvement of interventions.  
One way of improving treatment outcomes is by identifying central mechanisms by which 
treatments work. Treatment mechanisms refer to the chain of events or processes that explain 
how therapeutic change comes about [223]. The identification of mechanistic processes can lead 
to more effective treatments by means of explicitly developing strategies to target those 
mechanisms [224]. The first step to uncover treatment mechanisms is often to identify 
mediators of treatment effect. A mediator can be defined as an intervening variable that 
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statistically accounts for the relationship between an independent variable (such as treatment) 
and a dependent variable (such as perceived stress) [223].  
Only a few studies have conducted mediation analyses within randomized controlled trials of 
CBT for stress-reduction. In a study by Lloyd, et al. [225], increased psychological flexibility 
(i.e., the ability to focus on the current situation and take action in spite of difficult thoughts or 
feelings) was found to mediate reduction in emotional exhaustion in a non-clinical sample that 
underwent a brief, waitlist-controlled group intervention. Another study found improved 
emotion regulation to mediate the effect of a waitlist-controlled ICBT on level of perceived 
stress in a sample of employees with elevated levels of stress [198]. Yet another study 
investigated putative mediators of change by an internet-based intervention with the aim to 
improve recovery from work-related strain in teachers with sleeping problems [226]. Results 
indicated that the treatment, compared with a waitlist control, fostered an increase in recovery 
activities which in turn were related to lower perseverative cognitions (worry and rumination) 
and a subsequent reduction in disturbed sleep (the main outcome measure). Recently, our 
research group found that a reduction in impaired sleep partly mediated the effect of face-to-
face CBT (the intervention described in section 2.2.1.6) compared with an active control 
condition (RTW-I) on symptoms of exhaustion in patients diagnosed with ED [227].  
To summarize, although there is very limited knowledge to date regarding what factors bring 
about change in CBT for chronic stress, cognitive factors (such as psychological flexibility and 
perseverative cognitions), emotion regulation, and increased recovery (e.g., by improved sleep) 
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2.3 SUMMARY AND CURRENT DIRECTIONS 
It is clear that, although a bountiful body of research exists when it comes to understanding 
stress as a psychophysiological phenomenon and its relationship to clinical correlates and 
potential risk- and maintaining factors, there are important knowledge gaps when it comes to 
treatment. Most studies have evaluated interventions in work-settings using heterogeneous, non-
clinical samples [157-160]. Few randomized controlled trials of interventions targeting stress-
related disorders have been conducted. There is large heterogeneity between trials (regarding 
inclusion, interventions, and outcome measures), results are mixed, and many methodological 
issues remain to be solved before a solid evidence-base can be built for any one protocol 
targeting AD or ED [64, 161-163]. 
In clinical settings, patients suffering from chronic stress and stress-related disorders are many 
in number, yet few receive psychological treatment. Finding highly accessible, and efficacious, 
treatments that can be disseminated on large scale is of importance to meet patient demand and 
reach out to the many individuals who may perceive barriers to seeking help. There is vast 
support for the effectiveness of ICBT for many mental health conditions [197], and there are 
indications that ICBT might also be effective in reducing stress and exhaustion [198, 214, 216]. 
In fact, internet-based interventions have been suggested to be particularly suitable for patients 
diagnosed with AD, because the low treatment threshold and high accessibility could counteract 
the development of more severe mental health conditions [228]. However, to date only very few 
randomized controlled trials have investigated the efficacy of ICBT for patients with stress-
related disorders. 
Whereas treatment recommendations for AD generally suggest brief interventions [167, 228], 
treatment guidelines for ED in Sweden encompass a multitude of interventions, such as MMR 
[30], and sick leave recommendations are up to one year [41]. The differential 
recommendations, not based on a solid empirical ground, have great implications for societal 
and healthcare costs as well as for the care that patients receive. Irrespective of whether 
interventions are effective or not, outcomes should always be placed in the context of costs for 
the individual and for society as a whole in order to make wise choices as to which treatments to 
implement [229]. There is a dire need for health economic trials investigating cost-effectiveness 
and cost-utility of interventions before treatment recommendations are given. 
Because most interventions for chronic stress consist of “packages” of treatment techniques 
(even when under a common umbrella of CBT), more knowledge is needed as to how the 
treatments work, that is, which specific factors or processes mediate treatment effect? To date, 
knowledge about mediators and mechanisms of change in the treatment of chronic stress is 
limited. This staggers the improvement of existing protocols and the development of new 
treatment strategies [224]. More studies investigating putative mediators of treatment effect in 
randomized controlled trials are needed to bring the field of intervention research forward for 
stress-related disorders. 
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3 AIMS OF THE THESIS 
The overarching aim of the present thesis was to build and expand on the limited knowledge 
base regarding CBT as a treatment for stress-related disorders by further investigating clinical 
efficacy, cost-effectiveness, and mediators of change in treatment.  
3.1 STUDY I 
The aim of Study I was to evaluate the effectiveness of disorder-specific CBT, a return-to-work 
intervention (RTW-I), and a combination of the two (COMBO) for patients on sick leave due to 
a common mental disorder (CMD). We hypothesized that CBT, alone or as part of COMBO, 
would be superior to the RTW-I in reducing symptom severity, and that the RTW-I, alone or as 
part of COMBO, would be superior to CBT alone in reducing days on sick leave. For the 
purpose of the present thesis, the aim of Study I was also to evaluate the effect of a new CBT 
protocol used to treat patients with AD or ED, conditions for which no evidence-based 
treatment protocols exist. The main hypothesis was that CBT for these stress-related disorders 
would be superior to the RTW-I in reducing symptom severity.  
3.2 STUDY II 
The aim of Study II was to evaluate the CBT protocol for stress-related disorders used in Study 
I, when delivered as a therapist-guided internet-based intervention (ICBT). We hypothesized 
that, compared with a waitlist control condition (WLC), ICBT would result in significant 
improvements in level of perceived stress as well as in a range of other health related outcomes. 
We also investigated whether ICBT would have an effect on functional impairment and self-
rated work ability compared with the WLC. 
3.3 STUDY III 
The aim of Study III was to evaluate cost-effectiveness of ICBT from a societal perspective and 
from a healthcare perspective. Data on clinical outcomes and resource utilization was collected 
in tandem with Study II. We hypothesized that, compared with the WLC, ICBT would generate 
improvements at no or low net costs pre- to posttreatment, thereby making the treatment cost 
effective. 
3.4 STUDY IV 
In Study IV we aimed to further investigate the role of sleep impairment in mediating the effect 
of CBT on symptoms in patients with stress-related disorders (for our previous findings, see 
[227]). Based on data collected in Study II, we hypothesized that a reduction in impaired sleep 
would mediate the effect of ICBT on level of perceived stress and exhaustion compared with 
the WLC. We also aimed to explored whether a potential mediated effect would be moderated 
by participants’ level of impaired sleep at baseline. 
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4 THE EMPIRICAL STUDIES 
Studies I and II in this thesis were randomized controlled trials conducted with different 
samples. In Study I, a broader sample of patients with CMDs was included, of which a majority 
(72%) were diagnosed with AD or ED. Because CBT for stress-related disorders is the primary 
focus of this thesis, the overall results from Study I will be complemented by results from a 
recently published subgroup analysis of patients with stress-related disorders based on Study I 
(not included in the thesis) [230]. In Study II, only patients with a principal stress-related 
disorder of AD or ED were included. Studies III and IV are based on data from Study II. Table 
3 summarizes the sample characteristics of patients with stress-related disorders in respective 
trial. 
Table 3. Overview of demographic characteristics of patients diagnosed with AD or ED in the 
randomized controlled trials of Study I and Study II in this thesis 




Gender Women, n (%) 132 (86.8) 85 (85.0)  
Men, n (%) 20 (13.2) 15 (15) 
Age Mean age (SD) 43.7 (9.2) 47.2 (8.8)  
Range 23-64 26-65 
Principal disorder AD, n (%) 25 (16.4) 53 (53.0)  
ED, n (%) 125 (82.2) 47 (47.0) 
Mean durationb Mean years (SD) 0.6 (0.4) 1.6 (1.3) 
Highest educationc College/University  85 (55.9) 91 (91.0)  
Secondary school 2-3 
years, n (%) 
58 (38.2) 9 (9.0) 
 
Compulsory school 9 
years, n (%) 
10 (6.6) 0 (0.0) 
Psychotropic medication Antidepressants, n (%) 32 (21.1) 11 (11.0)  
Anxiolytics, n (%) 17 (11.2) 2 (2.0)  
Hypnotics, n (%) 39 (25.7) 17 (17.0) 
Received intervention CBTd, n (%) 52 (34.2) 50 (50.0) 
 RTW-I, n (%) 49 (32.2) N/A 
 COMBO, n (%) 51 (33.6) N/A 
 WLC, n (%) N/A 50 (50.0) 
Note: Study I consisted of primary care patients who were on sick leave due to a stress-related disorder. Study II 
consisted of a nationally recruited sample that was self-referred. AD, adjustment disorder; ED, exhaustion disorder; 
CBT, cognitive behavioral therapy; RTW-I: Return-to-work intervention; COMBO, combination of CBT and 
RTW-I; WLC, waitlist control condition. 
aTotal number of patients with stress-related disorders in Study I. The total study sample, including patients with 
social anxiety disorder, generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, post-traumatic 
stress disorder, major depressive disorder, and insomnia, was N=211. 
bIn Study I, Mean duration refers to disorder and was established through clinician assessment, whereas in Study II, 
Mean duration was self-rated by patients and refers to stress-related symptoms.                                                                                                          
cEducation level was assessed differently in Study I and Study II, why any higher education after secondary school 
here is referred to as “College/University”.  
dFace-to-face or via internet. 
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4.1 STUDY I: COGNITIVE BEHAVIOURAL THERAPY AND RETURN-TO-WORK 
INTERVENTION FOR PATIENTS ON SICK LEAVE DUE TO COMMON 
MENTAL DISORDERS: A RANDOMIZED CONTROLLED TRIAL 
4.1.1 Methods 
4.1.1.1 Procedure and inclusion 
Study I was a multisite parallel randomized controlled superiority trial in which 211 
consecutively recruited primary care patients on sick leave due to a CMD were randomized to 
either (1) CBT, (2) RTW-I, or (3) COMBO. Potential patients were referred to the study by 
general practitioners at four primary care clinics that were part of the study, and subsequently 
underwent a structured assessment procedure conducted by a licenced psychologist which 
included the Mini International Neuropsychiatric Interview [MINI; 231].  
Inclusion criteria were: (a) age 18 to 65, (b) being on sick leave (50-100% of full time) for at 
least one month but no longer than six months due to a CMD (specified as AD, ED, social 
anxiety disorder, generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, 
post-traumatic stress disorder, major depressive disorder, or insomnia), (c) a score of 4-6 on the 
0-8 scored clinician-administered Clinician’s Severity Rating [CSR; 232], (d) if on medication 
for a CMD, this had been stable for at least three months, (e) low risk of suicide, (f) no current 
self-harm, dementia, bipolar disorder, psychosis, or eating disorder, (g) no current substance 
abuse, and (h) ability to read Swedish.  
Of the total sample, 152 patients (72%) were diagnosed with a primary stress-related disorder 
(i.e., AD or ED).  
4.1.1.2 Outcomes 
Primary outcomes were (a) psychiatric symptom severity assessed using the CSR [232] at post-
treatment and at 6- and 12-months after randomization, and (b) net days of sick leave one year 
after randomization, data collected from the registry of the Swedish Social Insurance Agency. 
Secondary generic outcome variables were depression, anxiety, perceived stress, quality of life, 
and work ability. 
Although not reported in Study I, disorder specific self-rating scales were also administered at 
the different assessment points. Patients with AD and ED reported level of perceived stress 
using the 14-item Perceived Stress Scale [PSS, 233], and patients diagnosed with ED reported 
symptoms of exhaustion using the 22-item Shirom-Melamed Burnout Questionnaire [SMBQ, 
234] 
4.1.1.3 Treatments 
The CBT protocols used were disorder-specific protocols for respective CMD. In lack of 
evidence-based treatments for stress-related disorders, patients diagnosed with AD or ED were 
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treated with a CBT protocol developed by our research group that had been tested in clinical 
practice since 2007. A central aim of that treatment was to help patients achieve a balance 
between effortful expenditure and recovery in every day life, by scheduling idiosyncratic 
recovery activities and practicing relaxation, but also by incorporating traditional CBT 
components such as behavioral activation and exposure techniques to support patients in 
making value-driven and healt-promoting behavioral changes. Please see section 2.2.1.6 for a 
detailed description of the treatment. The treatment consisted of 9-13 weekly individual 
sessions.  
The RTW-I was a psychological intervention with the primary aim of supporting patients in 
taking steps toward a sustainable and healthy work situation. The treatment was developed by 
our research group and focused on establishing early contact with the employer [235] and 
planning graded exposure to the work place [186]. The RTW-I consisted of four central 
modules: (1) conceptualization, (2) psychoeducation (3) planning, and (4) monitoring adherence 
to the plan. In the conceptualization module, causes for sick leave were investigated, as were 
work-related goals and perceived barriers to return to work. The patient received information 
about the national social security system, the employers responsibilities, and medical guidelines 
for prescribing sick leave. Pros and cons with sick leave were discussed. Pychoeducation was 
based on a cognitive behavioral approach and included topics such as behavioral activation, 
exposure, and problem solving, with the specific aim to support patients in approaching work 
life and dealing with difficult emotions and situations related to the work place. Modules 3 and 
4 were based on gradual exposure to the work place, and included optional meetings with the 
employer and other parties involved in the sick leave process, such as the Social Insurance 
Agency and the general practitioner. The purpose of such meetings was to create a plan for 
sustainable work resumption and to support the patient in following that plan. The RTW-I 
consisted of 7-11 individual sessions that could be spread over a period of up to 20 weeks.  
The COMBO combined CBT and the RTW-I, starting with three RTW-I sessions (modules 1-3) 
and then monitoring the RTW progress parallel to administering the complete CBT protocol. 
Depending on which disorder-specific CBT protocol was administered, the COMBO could vary 
in length between 10 and 25 sessions, spread over a maximum of 25 weeks. 
4.1.1.4 Statistical analyses 
Mixed-effects models were used to analyze differences between conditions in symptoms and 
days on sick leave. Effect sizes for symptoms were calculated using Cohen’s d. To analyze net 
days on sick leave, we used full day equivalents, adjusted for days on sick leave one year before 
randomization.  
4.1.2 Results 
All treatments were associated with large reductions in symptom severity and secondary 
symptom outcomes pre- to posttreatment (d = 0.8-2.5). CBT was significantly superior to the 
RTW-I in reducing symptom severity (CSR; Cohen’s d = 0.4). No significant differences were 
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found between COMBO and CBT or COMBO and the RTW-I. Improvements were maintained 
to the 1-year follow-up. At that time, however, there were no longer any significant differences 
in symptom severity between treatments. There were no significant differences in net days of 
sick leave between treatments one year after randomization.  
4.1.2.1 Subgroup analysis of patients with stress-related disorders 
Subgroup analyses (published separately, please see [230]) of patients with stress-related 
disorders showed that the CBT protocol developed for this patient group was significantly 
superior to the RTW-I in reducing symptom severity pre- to posttreatment, with a moderate 
between-group effect size of Cohen’s d = 0.53. There was no significant difference between the 
COMBO and the RTW-I or between the COMBO and the CBT on this outcome. Within-group 
effect sizes on symptoms of perceived stress were large in all treatment groups (d = 1.20-1.67) 
pre- to posttreatment, as were effect sizes on symptoms of exhaustion (reported only by patients 
with ED; d = 1.50-2.04). There were significant interaction effects between time (pre- to 
posttreatment) and group (CBT, RTW-I, COMBO) indicating that patients in the COMBO 
reduced their level of perceived stress significantly more than patients in the RTW-I with a 
small to moderate between group effect size (d = 0.48). CBT was superior in reducing 
symptoms of exhaustion in patients with ED compared with patients with ED in the RTW-I (d = 
0.38). No differences were found between treatments with regard to net days on sick leave, and 
one year after randomization there were no longer any significant differences between 
treatments on symptom severity or on self-rated symptoms of perceived stress and exhaustion.  
4.1.3 Conclusions 
Disorder-specific CBT was indicated to reduce symptom severity in sick-listed patients with 
CMDs at a faster pace than a work-focused psychological intervention (RTW-I). The RTW-I 
did not contribute to reduced net days on sick leave to the 1-year follow-up compared with 
CBT. Because a large majority of patients with CMDs in Study I were diagnosed with a stress-
related disorder, it is plausible that findings are representative of this patient group. Indeed, this 
was confirmed in a separately published post hoc subgroup analysis [230]. Because this was the 
first randomized controlled trial in which the CBT protocol for stress-related disorders was 
evaluated, results need to be replicated. Seeing that stress-related disorders account for the 
largest increase in new sick leave spells [61] and for the longest sick leave periods in Sweden 
[72], further investigation into interventions that may prevent and shorten sick leave periods is 
warranted. 
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4.2 STUDY II: INTERNET-BASED COGNITVE BEHAVIORALTHERAPY FOR 
CHRONIC STRESS: A RANDOMIZED CONTROLLED TRIAL 
4.2.1 Methods 
4.2.1.1 Procedure and inclusion 
Study II was a randomized controlled efficacy trial in which 100 individuals diagnosed with AD 
or ED were randomized to ICBT (n = 50) or to a WLC (n = 50). Participants were recruited 
nationally via a newspaper ad and via social media. Primary inclusion criteria were (a) age 18–
65, (b) a primary diagnosis of AD or ED, (c) no substance abuse or dependence in the past six 
months, (d) no current or past psychosis or bipolar disorder, (e) no suicidal ideation (f) if on 
medication with a monoamine agonist, this had been stable in the past month, and (g) no on-
going psychological treatment.  
Inclusion criteria were assessed by a licensed psychologist using information collected in a 
telephone-conducted clinical interview comprising the MINI [231], and data obtained from an 
online screening. Randomization was stratified based on disorder (AD or ED) to ensure equal 
distribution of AD and ED across treatment conditions and enable subgroup analyses.  
4.2.1.2 Outcomes measures 
The primary outcome measure was the 14-item PSS [233]. Secondary outcome measures 
included the 22-item SMBQ [234], which was used to assess symptoms of exhaustion, and a 
range of other outcome variables such as depressive symptoms, anxiety, insomnia, and quality 
of life. Further, we assessed functional impairment and work ability. All outcome measures 
were self-report questionnaires filled in online before treatment start (pre), after the 12 week 
treatment phase (post), and (for the ICBT group only) 6 months after treatment (6MFU). 
4.2.1.3 Treatments 
The ICBT was a 12-week intervention delivered via a secure web platform where 
psychoeducation, worksheets, and exercises were presented primarily through text. Patients 
received weekly online support from an assigned therapist who gave gradual access to modules. 
Treatment content was almost identical to the treatment protocol used in Study I, and is 
described in detail in section 2.2.1.6 in the background of this thesis. Like in Study I, the 
treatment included work to increase daily recovery and improve sleep, as well as behavioral 
activation and exposure techniques to break fear-avoidance patterns. Patients in the WLC 
received no treatment during the 12-week main phase of the trial. They were immediately 
crossed over to ICBT after the 12-week treatment phase. 
4.2.1.4 Statistical analyses 
Continuous outcomes were analyzed using mixed-effect modeling, where the main statistical 
parameter of interest was the interaction effect of time (pre- to posttreatment) and study group 
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(ICBT vs. WLC). Subgroup analyses were conducted for AD and ED respectively. Within- and 
between-group effect sizes were calculated using Cohen’s d, and the proportion of patients with 
clinically significant improvement on the outcomes perceived stress (PSS) and exhaustion 
(SMBQ) were calculated using the criteria proposed by Jacobson and Truax [236]. All analyses 
were based on an intention to treat approach. 
4.2.2 Results 
Data loss was very limited at post treatment (1 of 50 in ICBT and 2 of 50 in the WLC did not 
complete self-rating scales) and at the 6MFU (3 of 50 in ICBT did not complete self-rating 
scales). Patients in ICBT on average completed 9.2 out of 12 modules (SD = 3.2). Average 
therapist time spent per week and patient was a little over 7 minutes over the course of 
treatment.   
Figure 3 illustrates the improvement on the PSS, which is indicative of the general pattern on 
almost all symptom outcomes measured in the study. Compared with the WLC, the ICBT led to 
large improvement in the primary outcome perceived stress (Cohen’s d = 1.09), and moderate to 
large improvement in all secondary symptom domains compared with the WLC. At 
posttreatment, 62% of patients in ICBT met criteria for clinically significant improvement on 
the PSS, as compared with 10% in the WLC. On the outcome measuring exhaustion, 48% of 
patients in the ICBT made a clinically significant improvement, compared with 6% in the WLC. 
All improvements were maintained to the 6MFU. No significant differences were found 
between groups (ICBT vs. WLC) on measures of functional impairment or work ability. 
 
Figure 3. Course of improvement on the primary outcome measure PSS-14. Error bars 
represent 95% Confidence Intervals.  ICBT, Internet-based cognitive behavioral therapy; 
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4.2.2.1 Subgroup analysis of AD and ED 
Subgroup analyses of respective diagnostic group (AD and ED) indicated that patients with both 
disorders benefitted greatly from the treatment. At baseline, patients with ED suffered from 
significantly more severe symptoms and level of disability compared with patients diagnosed 
with AD. Nevertheless, they reduced symptoms of perceived stress, exhaustion, and impaired 
sleep with waitlist-controlled effect sizes ranging from d = 1.22 to 1.27 at posttreatment. For 
patients with AD, corresponding effect sizes ranged from d = 0.88 to 0.95. No significant 
interaction effects of diagnostic groups were found on outcomes, with the exception of self-
rated health (on this outcome, only patients with ED made a statistically significant 
improvement). No significant differences were found between groups with regard to treatment 
completion or treatment satisfaction. 
4.2.3 Conclusions 
The ICBT protocol for stress-related disorders is indicated to be efficacious in reducing 
symptoms and increasing quality of life in a national sample diagnosed with AD or ED. The 
large effect sizes coupled with the minimal therapist time required and the relative simplicity of 
the treatment, suggest that ICBT could be a highly cost effective treatment with the potential to 
substantially increase treatment accessibility to those most in need. Because the WLC was 
crossed over to treatment after the 12-week main phase of the trial, no conclusions can be drawn 
about long-term effects of the ICBT. Studies using larger sample sizes and longer follow-up 
periods may be needed to establish the potential effect of ICBT on functional impairment. 
Regarding work ability, results from Study II are in line with findings in Study I, as well as with 
previous studies indicating that decreased symptoms are not necessarily related to perceived 












4.3 STUDY III: COST-EFFECTIVENESS OF THERAPIST-GUIDED INTERNET-
BASED COGNITIVE BEHAVIORALTHERAPY FOR STRESS-RELATED 
DISORDERS: SECONDARY ANALYSIS OF A RANDOMIZED CONTROLLED 
TRIAL 
4.3.1 Methods 
4.3.1.1 Procedure and inclusion 
This was a within-trial cost-effectiveness and cost-utility analysis with a time-perspective of 12 
weeks (pre- to posttreatment), conducted from a societal and from a healthcare perspective. 
Data was collected in tandem with the randomized controlled trial described in Study II. 
Nationally recruited participants (N = 100) diagnosed with AD or ED were included and 
randomized to a 12-week ICBT (n = 50) or to a WLC (n = 50).  
4.3.1.2 Outcomes and measures 
Remission rate was the primary clinical outcome for the cost-effectiveness analysis, 
operationalized as clinically significant improvement on the primary outcome 14-item PSS 
according to the Jacobson and Truax [236]. The EuroQol Questionnaire 3L version (EQ-5D), 
which measures health-related quality of life [240], was used for the calculation of cost-utility. 
The self-rated Trimbos and Institute Medical Technology Assessment of Costs Questionnaire 
for Psychiatry [TIC-P;  241] was used to measure resource utilization, from which societal and 
healthcare costs could be evaluated. Health outcomes and costs were surveyed pre- and 
posttreatment and (only in the ICBT group) at the 6MFU. For the cost-effectiveness and cost-
utility analysis, only the pre- to posttreatment assessments were used. All costs were converted 
to US $ from the Swedish Krona. 
4.3.1.3 Treatments 
Please see section 4.2.1.3. 
4.3.1.4 Statistical analyses 
Incremental cost-effectiveness ratios (ICERs) and incremental cost-utility ratios (ICURs) were 
calculated based on remission rates and health-related quality of life respectively, using 
bootstrap sampling (5000 replications). The probability of the treatment being cost effective 
(compared with the WLC) at different willingness to pay (WTP) scenarios was investigated. 
Several sensitivity analyses were conducted to support the robustness of results.  
4.3.2 Results 
The ICBT was more likely than the WLC to generate higher remission rates and slightly larger 
reductions in societal costs pre- to posttreatment. From a societal perspective, ICBT had a 60% 
probability of being cost effective at a WTP of $0, and a 96% probability of being cost effective 
at a WTP of $1000 for one additional patient in remission (see Figure 4, solid line). A 
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sensitivity analysis indicated that the ICBT would be cost effective even if the intervention cost 
was tripled (see Figure 4, dotted line). The cost-utility analyses supported the superiority of 
ICBT compared with the WLC from a societal perspective. 
 
Figure 4.  Cost-effectiveness acceptability curve from a societal perspective comparing internet-
based cognitive behavioral therapy (ICBT) with a waitlist control condition (WLC) over the 12-
week treatment period. Note: Solid line represents the probability of ICBT being cost effective 
under normal circumstances. Dotted line represents the probability of ICBT being cost effective 
based on a sensitivity analysis in which a 3-fold higher intervention cost was used.  
Taking a healthcare perspective (i.e., including only direct medical costs), the ICBT had a 97% 
probability of being cost effective given a WTP of $1000 for one additional patient in 
remission. Subgroup analyses showed that, although the ICBT was cost effective both for 
patients with AD and ED, it was more so for patients with AD. For these patients, there was a 
92% probability that ICBT was more cost effective than the WLC at a WTP of $0. The 
corresponding probability for patients with ED was 38%, although this probability increased to 
80% given a WTP of $1000. Sensitivity analyses supported the robustness of results, and 
pointed to the significance of reduced costs for presenteeism, as seen in the ICBT group 
compared with the WLC, in rendering treatment cost-effectiveness.  
4.3.3 Conclusions 
ICBT is likely to be a cost effective treatment compared with a WLC for individuals diagnosed 
with AD or ED, both from a societal and from a healthcare perspective. Most probably, ICBT 
leads to substantial symptom improvement at no net societal costs in a period of only 12 weeks. 
Even though some costs are associated with administering the treatment, the high scalability of 
ICBT means that the costs are likely to be quickly returned to society. The indication that ICBT 
























































4.4 STUDY IV: THE MEDIATING ROLE OF SLEEP IN INTERNET-BASED 
COGNITVE BEHAVIORALTHERAPY FOR CHRONIC STRESS: RESULTS 
FROM A RANDOMIZED CONTROLLED TRIAL 
4.4.1 Methods 
4.4.1.1 Procedure and inclusion 
Study IV was based on the randomized controlled trial conducted in Study II. Nationally 
recruited participants (N = 100) diagnosed with AD or ED were included and randomized to a 
12-week ICBT (n = 50) or to a WLC (n = 50).  
4.4.1.2 Outcomes and putative mediator 
The putative mediator investigated in Study IV was impaired sleep, as measured with the 
Insomnia Severity Index [ISI; 242]. Impaired sleep was assessed weekly over the course of 
treatment (week 1 to 11), as were the stress-related outcomes the PSS [233] and the SMBQ 
[234].  
4.4.1.3 Treatment 
Please see section 4.2.1.3.  
4.4.1.4 Statistical analyses 
We employed a parallel process latent growth modeling strategy within a structural equation 
framework to examine treatment effect on the growth trajectory of the outcomes (PSS and 
SMBQ) via the growth trajectory of ISI. Accurate confidence intervals based on the asymmetric 
confidence interval method (bias-corrected bootstrapping of 2000 samples) were constructed. 
We also conducted moderated mediation analyses to investigate whether the strength of the 
mediated effect was moderated by participants’ initial level of sleep impairment.   
4.4.2 Results 
A total of 84% of the sample reported some sleep difficulties pre-treatment (a score of 10 or 
above on the ISI) and 52% of the sample scored 16 or higher on the ISI which indicates clinical 
insomnia [243]. The waitlist-controlled effect size on the ISI at posttreatment assessment was 
large (Cohen’s d = 1.05). Tests of the indirect effects (based on the parallel process latent 
growth models), indicated that the larger reduction in perceived stress and exhaustion associated 
with the ICBT compared with the WLC, was mediated by a reduction in impaired sleep (PSS: 
αβ = -0.44, 95% CIasymmetric [-0.92, -0.14]; SMBQ: αβ = -0.08, 95% CIasymmetric [-0.15, -0.04]). 
Level of impaired sleep at baseline predicted the size of the mediation effects such that, for 
patients with a higher level of impaired sleep at baseline, the mediated effect of sleep on stress 
and exhaustion was accentuated. 
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4.4.3 Conclusions 
Improving sleep quality may be of importance for achieving successful treatment outcomes in 
ICBT for chronic stress in the form of AD and ED. This finding may be particularly pertinent 
for individuals with pronounced sleep impairment upon initiating treatment. Although the 
design of Study IV does not allow conclusions to be drawn regarding which treatment 
components contributed to the reduced sleep impairment, it is plausible that treatments aimed at 
reducing chronic stress could benefit from including interventions that specifically target sleep 
impairment, as this could play a role in overall symptom reduction. 
4.5 ETHICAL CONSIDERATIONS 
Study I and II were approved by the regional ethics committee in Stockholm, Sweden, and were 
judged to comply with international ethical guidelines for human research. All patients provided 
written informed consent and were informed of their right to leave the study at any time without 
penalty, judgement or further clarification. The studies were conducted in line with the 
Declaration of Helsinki Ethical Principles and were preregistered at ClinicalTrials.gov 
(identifiers NCT01636791 and NCT02540317) in order to protect against publication bias. 
4.5.1 On the issue of random allocation 
Random allocation to interventions may constitute an ethical dilemma in that participants may 
be assigned to a harmful intervention or be denied interventions with known positive effects. 
The specific CBT protocol used for patients with AD and ED in Study I and Study II lacked 
prior scientific evidence of its efficacy, and potential harmful effects were unknown. However, 
several studies of CBT for stress-reduction in heterogeneous populations have shown promising 
results, and more than 10 years of clinical evaluation of the CBT protocol for patients with 
stress-related disorders at Gustavsbergs primary care clinic suggest that the treatment is 
acceptable as well as efficacious. Taking into account that no evidence-based treatments exist 
for AD and ED, it was deemed important to test the efficacy of CBT for these specific 
disorders.  
In Study I, 141 of the 211 primary care patients suffering from CMDs were offered the best 
available treatment for their respective disorders. However, 67 of the 211 patients were 
randomized to an experimental treatment consisting of a novel return-to-work intervention 
(RTW-I). This is a deviation from national guidelines and is an important ethical consideration. 
However, only a minority of patients with CMDs that seek healthcare in in Stockholm receive 
evidence-based treatment. Our hope was that the general CBT-based psychoeducation that 
RTW-I offered, together with support in dealing with work-related difficulties, would contribute 
to improving patients’ well-being. We argued that the study had the potential to contribute to 
important knowledge regarding how best to treat patients with CMDs and how to support their 
return to work.  
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In Study II, 50% of participants were randomized to a WLC. When suffering from clinical 
levels of stress-related symptoms, waiting for three months might be difficult and there is a risk 
that symptoms deteriorate. Furthermore, the use of a WLC can be criticized for providing a 
favorable comparison. However, a WLC may represent a somewhat realistic scenario in such 
that no treatment guidelines exist for AD or ED, and many suffering individuals never get 
access to psychological treatment. To the best of my knowledge, Study II was one of the first 
studies of ICBT for AD and ED, and we therefore argued that it was reasonable to assess 
whether the treatment was efficacious before comparing to an active control. Before inclusion, 
all participants were informed that participation in the study meant that they would either be 
offered to initiate treatment immediately, or after 12 weeks. Because both groups were required 
to fill in weekly questionnaires about their mental health status, potential deterioration and 
suicide risk could be detected by study psychologists, in which case patients were contacted via 
telephone for suicide assessment.  
4.5.2 Treatment side-effects 
To date, knowledge about potential side effects of CBT for stress-related disorders is limited. 
To learn more, participants in both Study I and II were, at posttreatment, asked to document 
adverse events related to the treatment. In line with proposed recommendations to counteract 
negative side effects of treatment (which include monitoring, flexible contact with the therapist 
and flexible treatment schedule) [244], participants’ self-rated symptoms were monitored 
weekly throughout treatment in Study I and II, to enable quick detection of potential 
deterioration. Further, participants in Study II could contact their therapist at any time and 
expect a reply within 48 hours, and they could independently choose when and where to work 
with their treatment. Based on our clinical impressions of working with the treatment, the 
clinical gains of treatment clearly overshadow the negative effects.  
4.5.3 Handling of data 
All participants in Study I and II gave their written informed consent upon being included in the 
study, and all information that could be considered private (e.g., sick leave status and 
psychiatric symptoms) was handled confidentially and according to clinical routine practice and 
healthcare legislation. All self-rating scales were administered electronically, and data was 
entered and accessed using randomly generated passwords. Data was stored on an encrypted 
server using 128-bit SLL encryption to protect against hacking. Results of the studies were 
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5 DISCUSSION 
5.1 MAIN FINDINGS 
Studies I and II in this thesis indicate that a relatively brief CBT protocol can be efficacious in 
reducing psychiatric symptoms and increasing quality of life in patients diagnosed with AD or 
ED, both when delivered as a face-to-face treatment compared with another psychological 
treatment (RTW-I) and when delivered as an ICBT compared with a WLC. There were no 
differences between the face-to-face CBT and the RTW-I in net days of sick leave one year 
after randomization (Study I; see also [230]), and the ICBT was not superior to the WLC in 
increasing self-rated work ability (Study II).  
In Study III, we found that the substantial symptomatic improvement by ICBT was not 
associated with any net societal cost compared with the WLC, and the treatment was cost 
effective both from a societal and from a healthcare perspective in a period of only 12 weeks. 
Reduced sleep impairment was found to stastistically mediate the effect of ICBT on symptoms 
of stress and exhaustion, suggesting that impaired sleep might be an important target in the 
treatment of stress-related disorders (Study IV).  
5.1.1 Treating stress-related disorders with CBT 
5.1.1.1 Face-to-face CBT  
Findings from Study I are encouraging. The CBT protocol for stress-related disorders generated 
within-group effect sizes on symptoms of stress and exhaustion that are comparable with effect 
sizes found in previous studies on established CBT protocols for anxiety disorders [154] and 
depression [155]. Further, we found the CBT to be significantly superior to another 
psychological intervention (RTW-I), reducing symptom severity pre- to posttreatment with a 
moderate between-group effect size (d = 0.53). This finding is rather rare, because although 
several randomized controlled trials of CBT for chronic stress have found significant symptom 
reduction between pre- and posttreatment, most have failed to establish the superiority of CBT 
compared with other active control conditions [245]. Why is this? 
It is possible that the absence of between-group interaction effects in most previous trials can be 
partly explained by methodological limitations such as small sample sizes [e.g., 170, 173, 177], 
high drop out rates [170, 173, 179], or patients engaging in treatment outside of the study [e.g., 
179, 182-184]. It is also possible that an explanation can be found in different treatment content 
and somewhat different populations. For example, in the study by Sandahl et al. [173], the 
treatment included only cognitive interventions, and participants (who had been on sick leave 
over 90 days upon inclusion) were assessed to suffer from “work-related depression”. Meta-
analyses of interventions for work-related stress have found an inverse relationship between 
number of sessions/ number of treatment components and effect size [157, 159]. If this finding 
is applicable also to the treatment of chronic stress, it is possible that the absence of between-
group interaction effects in some studies can be understood by the fact that interventions have 
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been very comprehensive. For example, Stenlund et al. [179] evaluated the effect of an 
intervention that comprised over 140 hours total treatment time over a period of one year, 
including both CBT and qigong. This intervention did not generate superior effects on 
symptoms compared with qigong only. Similarily, Netterström et al. [184] found TAU (12 
individual sessions with a psychologist) to be equally effective in reducing symptoms as an 
intervention consisting of CBT, work-place diaglogue, and mindfulness-based stress-reduction. 
Hence, in speculation, it it possible that some interventions have included too many sessions or 
too many components. Indeed, in Study I we found that when CBT was combined with the 
RTW-I (COMBO), it was no longer superior to the RTW-I alone. Clinical experience from the 
trial suggested that the COMBO was too extensive or complicated both for patients and 
therapists, possibly diverting attention from treatment components in the CBT that were 
believed to target important mechanisms in stress-related disorders (e.g., recovery).  
The fact that both the CBT and the RTW-I reached equivalent sub-clinical symptom levels at 
the 1-year follow-up is in line with findings from previous trials [e.g., 171, 183]. This suggests 
that, even though symptoms of chronic stress may subside over time with different types of 
interventions (or by natural course), CBT might substantially shorten the suffering of patients 
by increasing the pace at which symptoms of stress and exhaustion are reduced.  
In summary, although the existing evidence base for CBT in treating stress-related disorders is 
still rather, findings from Study I indicate that patients with stress-related disorders might 
benefit greatly from a relatively brief, structured CBT protocol delivered in a primary care 
context, where most patients first seek help [52]. More well powered, randomized controlled 
trials investigating CBT for stress-related disorders are warranted. Preferably, the effectiveness 
of CBT should be further established before additional components are added, because complex 
interventions makes it more difficult to descipher which components may be central for 
symptom reduction.  
5.1.1.2 ICBT  
The ICBT tested in this thesis (Study II) generated larger between-group effect sizes compared 
with the pooled effects of other internet- or computer-based programs for stress (as evaluated in 
a meta-analysis) in terms of stress symptoms (d = 1.09 vs. 0.45), depression (d = 0.67 vs. 0.34), 
and anxiety (d = 0.57 vs. 0.32) [246]. One reason for this may be that previous internet-based 
studies of interventions to reduce stress have largely used non-clinical or undiagnosed samples. 
With lower symptom severity at baseline there is a risk of floor effects, and without clinical 
assessment samples are likely heterogeneous which could generate high variance in symptom 
levels. There are indications that greater symptom severity moderates the effect of ICBT, 
predicting higher response- and remission rates compared with patients with lower symptom 
severity [247, 248].  
Even though only a very limited number of studies of ICBT for stress-related disorders have 
been conducted, there are some methodologically sound studies of ICBT in which participants 
had elevated levels of stress [198, 214] to which we can compare our results, and one study in 
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which ICBT was evaluated for managers diagnosed with stress-related disorders according to 
the ICD-10 [216]. Compared with these studies, effects on mental-health outcomes found in 
Study II are generally equivalent. However, the ICBT in the present thesis generated a larger 
controlled effect size on impaired sleep (d = 1.05) compared with the other studies (d = 0.34-
0.52). It is possible that this difference can be attributed to the early interventions targeting 
increased recovery and disturbed sleep in our ICBT protocol. A lack of recovery during the day 
has been shown to increase the risk of disturbed sleep [249], and self-reported sleep quality has 
been found to be improved by a single session of psychoeducation regarding sleep in a primary 
care sample compared with a WLC [190].  
In the studies by Heber et al. [214] and Ebert et al. [198], no clinical assessment was conducted, 
and thus it is possible that their samples included participants suffering from other mental health 
problems not specifically related to chronic stress. In the study by Persson Asplund et al. [216], 
the ICBT protocol was evaluated in a sample of distressed managers rather than in a broader 
clinical population. In such, findings from Study II complement previous research on ICBT for 
stress-reduction by providing evidence that ICBT can be efficacious in reducing symptoms also 
in a national sample diagnosed with AD or ED. Results need to be replicated and future studies 
should compare ICBT to active control conditions. 
5.1.2 Does CBT have an effect on work-related outcomes? 
Although the primary aim of this thesis was to investigate the efficacy of CBT in terms of 
symptom reduction in patients with stress-related disorders, the fact remains that stress-related 
disorders are a very common cause for sick leave, often resulting in extended sick leave periods 
[47, 72]. Hence, questions regarding how sick leave can be prevented and how return to work 
can be facilitated are inevitably important.   
5.1.2.1 Face-to-face CBT 
There are indications that a combination of CBT techniques and interventions focusing on the 
work situation can be helpful to support return to work for patients on sick leave due to stress-
related disorders and other CMDs [180, 186, 250], perhaps more so than CBT alone [180]. 
Hence, in Study I, we hypothesized that the RTW-I (alone or in combination with CBT) would 
be superior to CBT as a stand-alone treatment in reducing sick leave for sick-listed patients with 
CMDs. Contrary to our expectation, however, sick leave reduced to the 1-year follow-up in all 
treatment arms. This was the case also when analyzing data from patients in the subgroup 
diagnosed with stress-related disorders [230]. Because no untreated control group or TAU was 
included in the design, we do not know whether all patients in Study I reduced sick leave more 
than patients in general would under usual care circumstances or whether a reduction in sick 
leave might be expected (independent of treatment) over the course of a year. 
Meta-analyses of the effect of treatment (including CBT) on sick leave in general populations 
with CMDs have found only small effects [195, 251], and in samples with stress-related 
disorders (where comparisons are most often made with care-as-usual) results have been mixed 
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[64, 162]. Hence, because Study I included three comprehensive treatments, it is possible that it 
was underpowered to detect differences in sick leave. Further, seeing that a majority of patients 
were diagnosed with ED, it is also possible that factors such as national sick leave 
recommendations affected length of sick leave. In Sweden, sick leave recommendations for ED 
are generous compared with those for other CMDs, ranging from 6 months to 1 year [41]. 
Benefits and regulations have been shown to strongly affect sick leave [252], and the absence of 
a between-group effect on sick leave in Study I might suggest that guidelines constitute a 
stronger predictor of this outcome than does specific treatment content. Of note, the separately 
published subgroup analysis indicated that, for patients in Study I that were diagnosed with 
other CMDs than stress-related disorders (i.e., depression, anxiety disorders or insomnia), there 
was a strong effect on sick leave in the RTW-I compared with disorder-specific CBT [230]. 
These results are very interesting, but because the subgroup was small (n = 59) and 
heterogeneous, they should be interpreted with causion and be considered provisional. 
In summary, evidence is limited when it comes to the efficacy of any psychological intervention 
in reducing sick leave in patients with stress-related disorders. More randomized controlled 
trials using large sample sizes and long follow-up periods are warranted. Also, an important 
question for future studies is whether CBT could prevent sick leave for patients with stress-
related disorders. In a study by Hägglund, et al. [219], face-to-face CBT was found to prevent 
sick leave for patients with CMDs who were not on sick leave upon commencing treatment. For 
those who were already on sick leave at treatment start, CBT did not have an effect on this 
outcome. If these findings are applicable to patients specifically diagnosed with stress-related 
disorders remains to be investigated.  
5.1.2.2 ICBT 
In Study II, the effect of ICBT on self-rated work ability was explored. Results indicated that 
the treatment did not lead to improvement in this outcome compared with the WLC. 
Interestingly, however, analyses of cost changes pre- to posttreatment in Study III (based on 
data collected in Study II) indicated a significant between-group interaction effect in favor of 
the ICBT on costs related to work cutback due to presenteeism. In other words, patients in the 
ICBT reported a significant decrease in number of days worked when ill across the 12-week 
treatment phase, leading to reduced costs for production loss compared with the WLC.  
Although promising, previous research suggests that the relationship between symptom 
reduction and work-related outcomes is generally weak [237-239]. Most previous studies of 
ICBT for stress-reduction have not found an effect on self-reported absenteeism or 
presenteeism, in spite of large symptom reduction [198, 214, 216]. Hence, whether ICBT for 
stress-related disorders can reduce work cutback due to presenteeism needs further 
investigation. Future studies of ICBT for stress-related disorders would also benefit from 
incorporating objective measures of sick leave using registry data.  
  55 
5.1.3 Can AD and ED be treated with the same protocol?  
This is an important question, because treatment recommendations for AD and ED tend to differ 
markedly. Most researchers within the field of AD, for example, agree that the first-line 
treatment should be a brief, low-intensive psychological intervention, such as self-help or 
internet-based treatment [e.g., 163, 167, 228]. For ED, however, the Swedish National Board of 
Health and Welfare recommends extensive, multimodal treatment [30]. Indeed, clinical trials of 
ED have sometimes comprised up to 140 hours of treatment over periods of up to one year [e.g., 
179]. The differential treatment recommendations are not based on any strong empirical ground, 
yet they hold important clinical and health economic implications.  
By stratifying randomization based on diagnosis in Study II, we were able to evaluate the effect 
of ICBT for patients with AD and ED separately. Findings suggested that the relatively brief 
ICBT was efficacious both for patients with AD and ED. Completion rate and treatment 
satisfaction did not differ between the diagnostic groups. Even though patients with AD 
consistently reported better mental- and physical health compared with ED, patients with ED 
gained just as much, if not more, from the intervention (as indicated by larger between-group 
effect sizes on almost all outcomes in the ED subgroup).  
So where does this leave us when it comes to treatment recommendations? The finding that 
ICBT was beneficial for patients with AD is in line with existing clinical recommendations. The 
finding that patients with ED gained such symptom relief from the ICBT is, however, rather 
surprising. One possible explanation could be that ICBT is a highly structured format, which 
might counteract therapist drift and thereby compensate for the limited amount of therapist 
contact [253]. It is also possible that patients with ED in Study II sought help in an earlier phase 
of symptom development compared with patients in some previous studies, as indicated by the 
relatively low rate of sickness absence (approximately 30%) in that subgroup. Of note, 
however, the relatively brief CBT protocol was indicated to be efficacious also when delivered 
to consequtively recruited primary care patients on sick leave due to stress-related disorders, of 
which 82% were diagnosed with ED [230].  
Taken together, our findings suggest that both patients with AD and ED can benefit greatly 
from the CBT protocol investigated in this thesis. Although patients did not significantly 
improve their functional impairment or work ability compared with the WLC in Study II, 
findings hold important clinical implications: An easily accessible, relatively short ICBT can 
significantly reduce suffering and increase quality of life in a large and highly disabled group of 
patients. If implemented in primary care, more patients could be treated earlier in the symptom 
development without increased societal costs. Although results need to be replicated, our 
findings suggest that it may be time to rethink the necessity of extensive, multimodal care for 
patients with ED, at least as a first-choice intervention. Regarding AD, future studies should 
investigate whether these patients might respond to a lower-dose intervention (e.g., ICBT 
consisting of 6 modules rather than 12), and whether treatment of AD might prevent the 
development of more severe disorders such as ED.  
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5.1.4 Cost-effectiveness of ICBT 
To the best of my knowledge, the health economic analysis of ICBT for the stress-related 
disorders AD and ED conducted in this research project is the first of its kind. Findings are in 
line with cost-effectiveness estimates presented in meta-analyses of ICBT for various clinical 
conditions [210, 254], and also with two recently published health-economic studies of cost-
effectiveness of ICBT for stress-reduction in employees with elevated levels of self-rated stress 
[221, 222]. These two studies found support for the cost-effectiveness of ICBT compared with 
waitlist control conditions from an employer’s perspective [221] and from a full societal 
perspective [222], with similar probabilities as found in Study III (>60% probability at a WTP 
of 0 for an additional improvement). Interestingly, in those studies, as in ours, cost-effectiveness 
was driven largely by a reduction in costs for presenteeism in ICBT. This is a promising finding 
because costs for presenteeism tend to be high in samples with chronic stress [106, 108]. Taken 
together, results provide preliminary evidence of cost-effectiveness of ICBT for stress-reduction 
from different stakeholder perspectives (the society, the employer, and the healthcare clinic) and 
for somewhat different populations with stress-related problems.  
As a sensitivity analysis in Study III we characterized heterogeneity in our findings by 
investigating whether the cost-effectiveness of ICBT differed in the diagnostic groups AD and 
ED. Characterizing heterogeneity is a criterium in the Consolidated Health Economic 
Evaluation Reporting Standards (CHEERS) checklist [255], and yet is often overlooked in 
health economic trials [256]. Findings suggested that, even though ICBT was cost effective in 
both diagnostic groups, it was clearly more so for patients with AD. These results can be 
understood by the fact that patients with ED made smaller cost changes relative to their controls 
than did patients with AD (although both diagnostic groups made large symptomatic 
improvements by ICBT). Seeing that patients with AD overall had lower symptom severity and 
functional disability compared with ED, a possible conclusion from these finding could be that 
offering treatment to patients early on in the development of chronic stress might be beneficial 
in terms of optimizing treatment cost-effectiveness and preventing increased societal costs. 
However, the fact that ICBT was highly cost effective also for patients with more severe 
symptoms of chronic stress (ED) is encouraging.  
Cost-effectiveness based on the comparison between different treatments regarding the relation 
between costs and, for example, remission rates, has a high clinical value. However, the cost-
utility of a given treatment, where costs are placed in relation to more generic health-related 
outcomes (such as QALYs), lends itself more easily to comparisons across clinical trials and 
clinical conditions, and is therefore often preferred by economists [256]. Thresholds of what can 
be considered value for money have been developed to guide economic decisions in healthcare, 
ranging from approximately US $26 000 per QALY in the United Kingdom to US $50 000 per 
QALY in Australia and the United States [256, 257]. In our study, we found that the probability 
of cost-utility of ICBT from a societal perspective was the same as that of cost-effectiveness 
(60% at a WTP of $0). This probability rose to 71% at a WTP of $25 000. Although thresholds 
of this type are increasingly criticized [257, 258], they give a frame of reference indicating that 
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ICBT for stress-related disorders as evaluated in Study III can likely also be considered to 
render cost-utility for patients with AD and ED. 
5.1.5 Sleep as a putative mediator of change in ICBT 
The finding from Study IV, that a reduction in impaired sleep mediated the effect of ICBT on 
symptoms of stress and exhaustion, is in line with results from a previously published study by 
our research group [227]. In that study, reduced sleep impairment was found to partially 
mediate the effect of face-to-face CBT (the same protocol as used in Study IV) on symptoms of 
exhaustion in sick-listed patients with ED [227]. In Study IV, we were able to extend findings 
also to patients diagnosed with AD, and propose that reduced sleep impairment mediates the 
effect of treatment not only on symptoms of exhaustion but also on perceived stress. The fact 
that CBT in the present study was delivered via the internet as opposed to face-to-face, supports 
the growing body of evidence suggesting that these two delivery formats may generate 
equivalent effects [211]. Our results are also in line with findings from prospective studies that 
indicate the importance of sleep in the prevention and rehabilitation of chronic stress [e.g., 133, 
259].  
Disturbed sleep is very common in patients with stress-related disorders. Indeed, more than half 
of participants in the ICBT trial scored 16 or higher on the ISI at baseline, which is indicative of 
clinical insomnia [243]. Importantly, however, although the waitlist-controlled effect size on the 
ISI pre- to posttreatment was large (d = 1.05), it is unclear precisely which treatment 
components that contributed to this effect. It is possible that the interventions targeting 
improved sleep (i.e., psychoeducation about sleep, sleep hygiene, and stimulus control) early in 
the ICBT played an important role reducing sleep impairment. There is empirical support for 
the efficacy of these interventions in the treatment of insomnia [156, 191]. However, Santoft et 
al. [227] found improved sleep to mediate the effect of face-to-face CBT on symptoms of 
exhaustion even though, in that study, interventions specifically targeting sleep were optional 
and delivered towards the end of treatment. Also, other ICBT protocols have generated 
equivalent effects on perceived stress and exhaustion as found in our ICBT trial, without 
directly targeting disturbed sleep (and finding only small to moderate effect sizes on the ISI) 
[198, 214, 216].  
Hence, there are likely different pathways through which sleep and other stress-related 
symptoms can be improved. Santoft et al. [227] argued, for example, that the reduced sleep 
impairment found in that study possibly could be attributed to the comprehensive focus on 
increasing daytime recovery in the treatment (by, for example, scheduling recovery activities, 
structuring the day, and practicing relaxation). A lack of recovery during the day has been found 
to increase the risk of disturbed sleep [249], and an intervention focusing solely on daytime 
recovery was found effective in reducing symptoms of stress and exhaustion compared with a 
WLC [136]. Further, putative mediators that were not measured in Study IV, such as emotion 
regulation that has previously been suggested to mediate reduction in stress by ICBT [198], may 
be intimately related with sleep. For instance, consistent sleep has been indicated to be 
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important for emotional self-regulation [260], and impaired sleep can lead to increased 
emotional reactivity [261-263].  
A limitation to Study IV was that we were unable to analyze how change in symptoms was 
temporally sequenced, meaning that we do not know whether change in sleep preceded change 
in symptoms of stress and exhaustion or vice versa. Nevertheless, against the backdrop of 
previous research, our findings suggest that improving sleep in patients with stress-related 
disorders may be of importance to reduce symptoms of stress and exhaustion. Given that the 
evidence base for treating insomnia is strong [156] whereas support for the treatment of chronic 
stress is still rather weak, it may be reasonable to recommend treatment protocols for chronic 
stress to include empirically supported interventions for improved sleep. This recommendation 
is substantiated by evidence from meta-analyses that interventions to improve sleep can be 
effective also in reducing secondary psychiatric symptoms [264, 265]. Further, self-help CBT 
for insomnia has been found to reduce perceived stress and day time fatigue with moderate to 
large within-group effect sizes in individuals with insomnia and comorbid mental health 
problems [266], and one study showed that ICBT for insomnia was as efficacious as ICBT for 
depression in reducing depression severity in patients diagnosed with both depression and 
insomnia [267]. 
5.2 GENERAL METHODOLOGICAL ISSUES 
5.2.1 Control conditions and follow-up 
Both randomized controlled trials in this thesis (Study I and II) have some limitations with 
regard to the control conditions used. In Study I, it was a limitation that no untreated or 
treatment-as-usual control condition was included. The inclusion of an untreated control group 
would have generated valuable information about sick leave that could be compared with results 
from other studies or to primary care in general. For patients with stress-related disorders, who 
received the new CBT treatment developed by our research group, an untreated control 
condition would also have generated important information regarding the impact on symptoms 
of CBT for stress-related disorders. This being said, including a fourth treatment arm in Study I 
would have reduced power to detect differences between groups. A much larger sample size 
would have been required, which was not feasible for practical and economic reasons.   
In Study II, the ICBT was compared with a WLC that, for ethical reasons, was crossed over to 
treatment immediately after the experiemtal phase. This was a limitation because it precluded 
comparisons between conditions at the 6MFU and did not enable control over potential 
confounders between posttreatment and the 6MFU. The use of a WLC was motivated by the 
fact that research on CBT for stress-related disorders, particularly in the form of ICBT, is still in 
its early stages. We wanted to protect against basic threats to internal validity, such as 
spontaneous remission and regression towards the mean, and also reduce the risk of type-II 
error [268]. Further, because access to psychological treatment is generally limited, and waiting 
for three months is likely to be a common scenario for patients who struggle with mental health 
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problems [196], we considered a WLC to represent a realistic scenario for patients with stress-
related disorders.  
5.2.2 Assessment procedures and measures  
Measuring stress in general is a challenge, given the complexity of the concept [269]. Assessing 
and measuring stress-related disorders is also associated with some specific challenges. For 
example, few structured clinical interviews include diagnostic modules for AD, and even though 
specific measures of AD have begun to emerge (structured clinical interviews and self-report 
questionnaires), these have so far been insufficiently validated (for a summary, please see [25]). ED, 
being a Swedish diagnosis, is not included in structured clinical interviews such as the MINI (used 
in the current thesis). The Karolinska Exhaustion Disorder Scale [KEDS; 43] was developed to 
specifically measure symptoms characteristic of ED. However, this is a self-rating questionnaire and 
not a diagnostic tool. Further, the fact that the KEDS is almost exclusively used in Sweden makes it 
difficult to compare results with those reported in international studies of chronic stress.  
In the present thesis, we used well-validated self-rating scales for all symptom outcomes. To 
assess perceived stress and symptoms of exhaustion we used the PSS and the SMBQ 
respectively. The PSS, although not a disorder-specific scale in any sense, is the most commonly 
used measure of perceived stress [270] and is often used as a primary outcome measure in clinical 
trials of chronic stress. As for the SMBQ, although it is a measure of the burnout construct, it has 
shown high correlation with other measures of chronic stress [55, 271], and the fact that it is 
frequently used as an outcome measure in international studies of chronic stress enables 
comparisons across trials.  
To further our understanding of the stress-related disorders AD and ED, it would have been 
valuable to conduct structured clinical assessment in Study II, both at posttreatment and at the 
6MFU, using the CSR to assess symptom severity at the different assessment points (as in Study I). 
This would also have enabled further comparisons between the efficacy of CBT as a face-to-face 
treatment (in Study I) and as an ICBT (in Study II) in which we used slightly different samples. Due 
to practical and economic factors, however, this was not feasible. 
Regarding the assessment of impaired sleep as a putative mediator (Study IV), the ISI is a 
commonly used measure that has illustrated acceptable internal consistency (Cronbach’s α = 0.86 
in our sample) as well as good convergence with clinical evaluation of sleep disturbance 
severity and sensitivity to detect changes in treatment [243]. Nevertheless, future studies might 
complement this measure with the use of objective sleep measures [272]. 
5.2.3 Generalizability 
In the clinical studies included in this thesis, a large majority of patients with stress-related 
disorders were middle-aged, highly educated women (see Table 3). This limits generalization of 
findings to the full spectrum of individuals suffering from stress-related disorders. Whereas the 
effect of gender on outcome in CBT is generally limited [273], level of education has been 
found to predict outcome in guided self-help CBT [274], and it is possible that this could be the 
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case also for ICBT. This being said, the demographics of our samples are similar to other 
clinical trials of chronic stress [e.g., 38, 184, 214], and may be representative of those who are 
most prone to seeking help in healthcare settings. More studies are needed investigating how to 
reach out to other groups of individuals suffering from stress-related disorders that may feel 
stigmatized in the healthcare system or encounter other obstacles to seeking and receiving help.  
5.3 FROM HERE ON AND FORWARD 
5.3.1 Regarding the effectiveness of CBT 
As has been noted throughout this thesis, there are no evidence-based treatments for chronic 
stress in general or for stress-related disorders specifically. Even though this thesis has 
contributed to the relatively limited research regarding CBT as treatment for stress-related 
disorders, more randomized controlled trials are needed, using different recruitment strategies, 
different control conditions, and long-term follow-up of outcomes. I encourage other research 
groups to further investigate the protocol used in the present thesis as a face-to-face treatment, 
as an internet-based treatment, and also as a group treatment. Group treatment for stress-
reduction is recommended by the Swedish National Board of Health and Welfare [30] as one of 
many interventions for ED, and is commonly used in clinical settings as a means of increasing 
treatment access and reducing costs. When it comes to costs, future trials should routinely 
include robust economic evaluations so that effects of different treatment formats can be placed 
in relation to their costs and enable wise decisionmaking regarding how best to use limited 
healthcare resources while providing the most effective treatment.   
5.3.2 Regarding sick leave interventions  
More studies need to investigate what interventions could effectively target work-related 
outcomes such as improved work ability, reduced presenteeism, and reduced sick leave. Even 
though psychological interventions may have some effect on sick leave compared with control 
groups [195, 251], the evidence base for any particular type of return-to-work intervention is 
limited. Prevention of sick leave is likely equally important to study. There are indications that 
CBT may prevent sick leave for patients with CMDs who are not on sick leave upon initiating 
treatment [219]. This finding needs to be replicated and tested in samples specifically diagnosed 
with stress-related disorders. Further, organizing work- and school environments to promote 
mental health could be of importance to reduce the risk of chronic stress and subsequent sick 
leave. To date, however, evidence for the effect of primary interventions targeting organizations 
is limited [158, 275]. 
5.3.3 What works for whom? 
Even though we found the “treatment package” investigated in this thesis to be effective in 
reducing symptoms for many patients with stress-related disorders, there is clearly room for 
improvement. AD and ED together constitute a group with a broad range of symptoms and level 
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of disability, potentially incorporating different symptom trajectories. Studying moderators and 
mediators of treatment effect could help to descipher what works for whom, and enable the 
development of more streamlined and tailored treatment strategies. Indeed, transdiagnostic and 
tailored CBT delivered via the internet holds promise for the treatment of anxiety and 
depression, and can effectively deal with comorbidity [276]. Future studies might compare the 
structured ICBT used in the present thesis with other formats for delivering the treatment. 
Factorial trial designs, in which different treatment modules can be compared within the same 
study, could be an effective approach [197]. 
Given the plethora of constructs used to operationalize chronic stress in the international 
research litterature (and now, new diagnostic criteria for AD in the ICD-11 that differ markedly 
from DSM-5 criteria [e.g., 163]), it is possible that a more process-based approach to studying 
interventions for chronic stress and stress-related disorders is a promising avenue for future 
studies.  
5.3.4 Dissemination and implementation 
Even though ICBT has repeatedly been shown to be an effective treatment for a wide range of 
psychiatric disorders [210], studies indicate that most people still would prefer face-to-face 
interventions to internet-based therapy [277]. Specifically for more severe symptom levels, 
there seems to be negative attitudes amongst patients as well as amongst clinicians and 
stakeholders (such as insurance companies) when it comes to internet-based treatment [197]. 
This may constitute a hurdle in the dissemination and implementation of ICBT in regular 
healthcare settings. It is possible that there is a general lack of knowledge and understanding of 
the positive effects of ICBT, that could partly be overcome by education and training. 
From the perspective of different stakeholders, a blended treatment approach (i.e., using 
internet-based interventions as a complement to face-fo-face interventions) is often preferred to 
ICBT as a stand-alone intervention [278]. Many randomized controlled trials of ICBT include 
no face-to-face contact with the therapist, and assessments are usually conducted via the 
telephone [197]. In contrast, a blended approach for patients with stress-related disorders in a 
healthcare setting might include coming to the clinic for somatic and psychological assessment, 
receiving face-to-face information and education about ICBT, and establishing a contact with 
the therapist. During ICBT, patients would have the possibility to book a physical session at the 
clinic if needed. Upon completing ICBT, patients would again visit the clinic to follow up 
treatment gains or possible deterioration, and discuss the need for potential further 
interventions. This procedure is in line with a stepped care approach, which is a model of 
healthcare delivery that is indicated to be an effective and resource-efficient way to treat CMDs 
in primary care [e.g., 279].  
Treatment within a stepped care model has been suggested to be particularly suitable for 
patients diagnosed with AD [167]. Because AD has a potentially transient nature, brief internet-
based interventions may be a good first-line treatment for this patient group [228]. Results from 
Study II indicate that also patients with ED can benefit greatly from a relatively brief ICBT. For 
 62 
patients that are not in remission, it is possible that individual face-to-face treatment should 
conduce a next step in the treatment process, involving other healthcare professionals when 
needed. The central benefit of a stepped care model is that, because many patients are likely to 
be helped by less intense treatment, clinicians have time to administer more complex treatments 
for those in need, without the need for long waits or unneccesary referrals.  
5.3.5 Concluding remarks 
The studies in this thesis provide support for the efficacy of a relatively short and easily 
administrated CBT protocol for symptom reduction in patients with AD and ED. We provide 
preliminary evidence that the treatment can be effective also when delivered via the internet as a 
therapist-guided intervention, and that this format can be a cost effective alternative compared 
with waiting for treatment for 12 weeks. Finally, we found impaired sleep to be a putative 
mediator of treatment effect in ICBT, which might guide the development of future treatment 
strategies.   
This thesis is hopefully the first of many to come that will specifically target treatment for 
stress-related disorders in a primary care context, where many individuals seek and recieve 
help. Throughout the work with my doctoral project, I have been startled by the limited number 
of high quality, randomized controlled trials within the area. I plead for effectiveness studies, 
dismantling studies, and clinical implementation studies. I, for one, will continue to further 
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in 2009 and schooled me well. Jens and Robert, we spent many hours developing the early 
version of the CBT protocol for stress-related disorders. Thank you for good times! 
Josefine Särnholm and Gunilla Berglund, thank you for encouraging me to believe that I, too, 
could be a researcher and dare to take the steps required to become a doctoral student.  
Karoline Kolaas, former colleague, fellow PhD student, life coach, and best friend. I met you 
in 2009 and since then you have been one of the most important people in my life. You 
probably know me as well as I know myself (perhaps better). Sharing work, gossip, hardship, 
great jokes, yoga, trips, running, pizza, and whine with you has contributed to making the 
past decennium the mest in my life. May we always continue!    
Pirkko and Hans, thank you for always being there for my family, for loving our children and 
for helping out with any practical matter. Hans, I truly appreciate your curiosity in my work – 
you are probably the only one in my family who ever read the CBT protocol or any of my 
publications! 
Mamma and Pappa, thank you for giving such loving and patient support throughout school 
and in everything that I have done in life. I have always felt that I have a safe place to return 
to whenever my escapades don’t turn out as expected. In fact, thanks to you I dare to take 
risks and follow my heart. Malin, Karin, and Frida, my amazing sisters, knowing that you are 
there for me and look out for me is such a luxury in life. I love you all so very much.   
Finally, my daughers Julia, Majken and Lovis. I never knew the meaning of unconditional 
love before you came to me. Spending time with you will always be my first hand choice. 
Mattias, throughout our ups- and downs you have been there for me when it mattered. You 
will never cease to fascinate me, simply by being you.  
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